TheBudtender - IE + UK Competitor Mega-Table v2

Executive Summary

• No IE or UK hemp ecom shop has a complete schema stack. Out of 20 retailers profiled, two have any visible JSON-LD (Dr. Hemp Me, HighWay), and none have layered FAQ + Product + Article + Organization at once. This is the single largest unowned ranking lever in both markets.
• CoA transparency is theatre, not infrastructure, almost everywhere. Most peers say "third-party lab tested" without surfacing a single PDF. Only Dr. Hemp Me (QR on label), Provacan (Lab Reports nav page), and Celtic Wind (downloads page) actually deliver. TheBudtender's existing public CoA page already puts it in the top quartile for compliance UX.
• Novel-cannabinoid breadth is the IE wedge. HiddenCBD and HHCP.ie are the only IE peers with HHC + HHCP + THCP at one shop. Dr. Hemp Me, Little Collins, Celtic Wind, 123CBD, Mama Kana, Naturecan all stop at CBD/CBG/CBN. TheBudtender already has the full stack including THCP.
• Age-gate enforcement is rare, brand-protective, and undervalued. Two IE shops enforce it (Celtic Wind, Little Collins). UK shops mostly do not. TheBudtender's 18+ ID checkout is a moat for a regulator-friendly positioning, especially as PSA-2016 enforcement firms up.
• Top-tier competitor SEO spend is in the EUR 6-15k/m range (Provacan, Dr. Hemp Me, HempHash, Naturecan group) once content + link-building + technical + agency fees are stacked. The proposed EUR 4-5k/m anchor is conservatively positioned below market leaders, justified.

---

IE Top 10 Mega-Table

---

UK Top 10 Mega-Table

---

Doctor-Level Analysis: IE Top 3

1. Dr. Hemp Me (drhempme.ie)

The most digitally mature IE hemp ecom by a wide margin. Five-plus years of brand age, HIFA membership for three-plus years, 1,000-plus five-star reviews on the homepage and 30-50 individual reviews per product, JSON-LD Product and Organization schema present, QR-coded CoAs on physical labels, founder-led "About Me" content, Calendly-integrated free consultation booking, 60-day money-back guarantee, benefit-tagged navigation (Recovery, Calm, Sleep, Focus, Libido). Estimated monthly SEO spend: EUR 4-7k. That breaks down to roughly EUR 2-3k content (3-4 long-form articles a month plus product copy refresh), EUR 1-2k link-building (HIFA + Irish health blogs + niche review sites), EUR 1-2k technical and analytics, plus an in-house or part-time SEO operator. They are the IE benchmark for what a well-run CBD shop looks like at retainer-supported scale. Their gap is novel cannabinoids, flower SKUs, and HHC/HHCP/THCP positioning. TheBudtender ships exactly that gap.

2. Little Collins CBD (littlecollinscbd.com)

A founder-named family business (JP and Ide O'Brien, est 2018) running three physical dispensaries plus a Melbourne-style cafe alongside ecom. Real-world entity signals are strong: named owners, three storefronts in Dublin, Galway, and Kilkenny, sister company (Plumes), HIFA membership, crypto payment, age-verified checkout. The digital execution lags the physical brand. Schema is partial (Shopify default), no FAQ schema, lab testing is mentioned in metadata but not exposed via a public CoA UX, no novel cannabinoid range. Estimated monthly SEO spend: EUR 2-4k, mostly content and basic technical hygiene with modest link work via Irish lifestyle press. They win on entity authority and lose on digital depth. TheBudtender beats them on novel cannabinoids, schema, and CoA UX, but cannot beat their three-shop entity moat directly. Position TheBudtender as the digital-native, novel-cannabinoid, Colorado-provenance counterpart, not a Little Collins replacement.

3. HiddenCBD (hiddencbd.com)

The closest direct IE peer on novel-cannabinoid breadth. Sells HHC, HHCP, THCP, THC-JD, plus full CBD range. Athlone HQ, wholesale program, same-day shipping. Brand polish is mid-tier, schema is absent, no public CoAs surfaced, no age gate, no founder narrative, no FAQ hub. Estimated monthly SEO spend: EUR 1-3k, likely a single in-house operator handling product copy and basic ecommerce SEO with limited link-building. They prove there is real demand for novel cannabinoids in IE without yet capturing the trust-tier positioning. TheBudtender wins by layering everything HiddenCBD lacks (Colorado provenance story, age-gated checkout, public batch-level CoA, schema stack, founder entity) on top of an equivalent or broader product range. Treat HiddenCBD as the demand-validation case in the proposal, not the benchmark to beat on spend.

---

Doctor-Level Analysis: UK Top 3

1. Provacan (provacan.co.uk)

UK CBD market leader by Trustpilot social proof (20,000-plus customers, 4.8 stars, 200-plus reviews per flagship SKU). Tiered SKU architecture (Vital, Complete, Advanced, Ultimate), kosher certification, registered limited company, dedicated Lab Reports navigation page, modern design language, Trustpilot widget integration. Estimated monthly SEO spend: EUR 8-15k. That is a full agency retainer (EUR 4-6k), in-house content lead (EUR 2-3k), structured digital PR plus link-building (EUR 2-4k), plus paid media oversight on Google Shopping and Meta. They own "best CBD oil UK" through brand authority more than schema discipline (no JSON-LD visible), which means a schema-first challenger has an opening. No HHC/HHCP/THCP, no flower, weak founder narrative for E-E-A-T. TheBudtender cannot match Provacan brand spend, but can outflank on novel-cannabinoid SEO clusters and AI citation through schema + entity work that Provacan has not invested in.

2. HempHash (hemphash.co.uk)

Broad UK flower/hash retailer, est 2018, 10,000-plus Trustpilot reviews, 4.8 rating, multi-brand stockist (Rochanna, Ivory, 5CBD, British Cannabis). Strong on volume and review velocity, weak on every structured-content lever. No JSON-LD, no FAQ schema, no public CoA UX, no founder narrative, no age gate. Estimated monthly SEO spend: EUR 4-8k, weighted toward content and link-building (Trustpilot velocity, niche affiliate placements, multi-brand stockist relationships) with limited technical SEO. They prove that flower-led volume sells in the UK without a schema moat, which means TheBudtender does not have to outspend them on links to beat them in AI Overviews and ChatGPT citations. Schema + FAQ + entity work alone wins that lane.

3. BudMother (budmother.com)

Direct UK peer on novel-cannabinoid breadth. HHC, THCA, THCP, 10-OH-HHC, CBD across flower, hash, vape, edibles, gummies, chocolate, oil. Named founder (James, CEO), 10,000-plus customers, 4.9 rating displayed (platform unidentified). Sourcing narrative (Italy, Spain, Austria, Switzerland), military discount. Weak on schema (none visible), no public CoAs, no age gate. Estimated monthly SEO spend: EUR 2-5k, likely a single SEO contractor or small agency handling content and basic link-building. They are the closest TheBudtender analog in the UK and the most useful comparison for the proposal. The wedge against BudMother is Colorado provenance (vs European-blend sourcing), public batch-level CoA, age-gated compliance posture, and schema layered with FAQ and Article markup. Same product depth, dramatically tighter trust signal.

---

What This Tells Us About the EUR 4-5k/m Anchor

The proposed EUR 4-5k/m for TheBudtender lands at the top of Tier 2, the spend tier of established mid-market IE leaders like Dr. Hemp Me. That is the right anchor for a brand that wants to challenge Dr. Hemp Me on the IE side and BudMother on the UK side within 9-12 months. Below this tier, you cannot fund the schema work, content depth, and link-building velocity needed to displace Tier 2 peers. Above this tier, you are matching Provacan, which is a different argument and a different timeline.

The defensible pitch: EUR 4-5k/m gets TheBudtender the IE schema crown (no peer has it), the novel-cannabinoid AI citation share (no peer is positioned for it), and a 6-month path to displacing HiddenCBD as the IE novel-cannabinoid leader, with UK upside as a parallel motion. That is a Tier 2 spend buying a defensible Tier 1 wedge, because no Tier 1 IE/UK peer has invested in the levers TheBudtender will own.

---

Cross-Market Arbitrage (IE + UK)

UK patterns not yet in IE (TheBudtender opportunity):

• THCA flower SKUs (BudMother, Mello UK push it; no IE peer sells it)
• H4CBD product line (Mello UK; no IE peer)
• 10-OH-HHC (BudMother UK; no IE peer at all)
• Indoor vs sungrown cultivation transparency on PDP (Originals UK; no IE peer)
• Bulk-tier pricing with weight discounts (HempElf UK; only 123CBD lightly in IE)
• Branded own-label cartridge SKUs (Canna Buddie at Only-Hemp; no IE equivalent)
• Multi-brand stockist model (HempHash carrying Rochanna, Ivory, 5CBD; no IE peer at this scale)

IE patterns not yet in UK (TheBudtender opportunity):

• Public 18-plus ID verification at checkout (TheBudtender, Celtic Wind, Little Collins; almost no UK peer enforces)
• Heritage and provenance brand story (Celtic Wind = Irish soil; TheBudtender = Colorado soil; no UK peer has equivalent depth)
• CoA-per-batch with QR on label (Dr. Hemp Me model; rare UK-side, Provacan has page only)
• HIFA-style trade-association membership signal (Dr. Hemp Me, Little Collins; no UK equivalent visible across peers profiled)
• FAQ schema for legality questions (Dr. Hemp Me partial; no UK peer)

The asymmetric play:

• IE-side: import UK product breadth (THCA, H4CBD, 10-OH-HHC, indoor/sungrown labels, bulk pricing) paired with IE-grade compliance (age gate, batch CoA, FAQ schema). TheBudtender becomes broadest range AND most compliant IE shop.
• UK-side: import IE compliance posture (age gate, batch CoA, FAQ schema, founder entity) into a UK novel-cannabinoid market that is structurally a Wild West. TheBudtender becomes the trust-tier UK retailer where peers look like Shopify dropshippers.
• AI citation: no shop in either market has Product + FAQ + Article + Organization schema layered with a 30-page education hub. Ship that, increased likelihood of citation in ChatGPT, Perplexity, and Google AI Overviews follows within 60-90 days.

---

Confidence Flags

• thecbdflowershop.co.uk: 403 on fetch, listed per industry press, schema and traffic unverified.
• canavape.com: timeout on fetch, included from cross-referenced industry press, recommend re-verify before deck.
• naturecan.ie: redirects to uk.naturecan.com/ie, regional view of UK group, IE-specific traffic share unclear.
• hempcompany.ie: search-snippet only, fetch blocked, DR and schema unverified.
• All DR and traffic figures are educated estimates anchored on age, ranking signals, review volume, content depth. Replace with Ahrefs / SimilarWeb pulls before the proposal deck.
• All scoring is heuristic, derived from visible HTML signals and industry-press cross-references. Treat as directional, not quantitative.
• Estimated monthly SEO spend ranges are inferred from observable output (content cadence, link profile depth, technical polish, agency-vs-in-house tells in HTML and schema). Direct sources unavailable.

---

What Goes Into the AI Trust Sources Table (Phase 8, separate doc, NOT competitors)

Reddit, Trustpilot, Boards.ie, Cosc.ie, Leafly UK, Project CBD, HSE.ie, GOV.UK, HFMA, HIFA. These appear repeatedly in AI answers about IE/UK CBD but per Rule 09 are aggregators, not competitors. Founder-led answers on Reddit, Trustpilot review velocity, and HIFA dialogue are parallel workstreams to ranking the TheBudtender domain itself.

TheBudtender.com - Deep SEO + AI Ranking + Schema Audit

Executive Summary

Three numbers that matter:

• 244 products / 0 with body_html descriptions in product DB. Every product description is rendered in the Shopify theme template, not stored on the product object. SEO and AI engines see thin product pages.
• 2,531 Judge.me reviews live, 0 surfaced as schema.org Review/AggregateRating to Google or AI crawlers. Massive E-E-A-T asset wasted.
• 0 indexed blog posts. /blogs/news returns 404. Top-of-funnel queries ("is HHC legal in Ireland", "CBD vs Delta-9 effects") have no content path on this domain.

Top 3 critical gaps:

• Schema is broken at the product level. Product pages emit Organization + Brand + Offer JSON-LD, but no Product type with aggregateRating, review, or sku. Google merchant-style rich results and AI cite-eligibility are both blocked.
• Regulatory posture is dangerously thin for an EU cannabinoid retailer. Medical disclaimer is ~280 words, names zero cannabinoids, references zero laws (Novel Food, Misuse of Drugs Act, Irish HPRA, German MedCanG). On a Tuesday call this is the single biggest revenue-and-survival risk to flag.
• No content marketing layer. Blog 404, FAQ has 4 questions covering 3 of 10 critical buyer topics, no jurisdiction guides, no condition pages, no dosing guides. AI engines have nothing to cite.

Top 3 quick wins (Pri 1, executable in 90-day window):

• Backfill body_html on all 244 products + emit full Product schema with AggregateRating from Judge.me. Estimated 4-6 days, every product page becomes both SEO and AI-citable.
• Build a 12-page Trust + Compliance hub (per-jurisdiction legality pages, lab-testing process, founder bio, CoA index, ingredients glossary). 2-3 weeks. Sets E-E-A-T floor.
• Launch a 24-post content engine on /blogs/news targeted at the 30 buyer queries we mapped below. 90-day output, recurring AI-citation surface.

---

1. Technical SEO

Platform: Shopify (theme 162909946183, Dawn-derived) behind Cloudflare. Server-timing ~1.07s edge, Shopify-complexity-score 8360 (top 5% of Shopify stores). Multi-locale: EN (IE default), de, fr, it, uk + EU variants, 33 sub-sitemaps.

Page weight (homepage)

CWV (heuristic, not Lighthouse-run)

• LCP: high risk. 32 stylesheets + 47 scripts; 8360 complexity score.
• CLS: medium. Judge.me carousels post-paint.
• INP: high. Heavy JS (analytics + Judge.me + theme + age-gate + currency).

Indexation

• robots.txt blocks /cart, /checkout, /search, /policies, faceted collections (good - no duplication).
• No GPTBot/ClaudeBot/PerplexityBot/Google-Extended directives. Correct posture for AI-ranking play.
• AhrefsBot crawl-delay 10s; MJ12 + Pinterest also delayed.
• "Checkouts are for humans" notice present.
• Sitemap has no lastmod dates (Shopify default; missed freshness signal).

Mobile: Dawn-derived = mobile-first. Age-gate full-screen modal works on mobile but gates first paint for crawlers; content-gating risk to indexed snippets.

Pri 1 technical fixes

---

2. On-Page SEO

Title and meta

• Home title: "Budtender Premium Hemp Products | Hemp Dispensary | Ireland, UK & EU" (66 chars; close to truncation; brand-first).
• Home meta description: "The Budtender is an Irish distributor of premium Hemp derived products. We distribute hemp products in Ireland, UK and throughout Europe." (137 chars; functional but generic; no CTA).
• Product title example: "Apples & Bananas | 2ml Liquid Diamonds" (no brand suffix, no jurisdiction, no shopping intent modifier).

Heading structure

• Home: 1 H1, 12 H2, 3 H3. Acceptable.
• Product page: 1 H1 (product title only), no H2 for sections like "Effects", "Lab Results", "How To Use". Missed semantic structure.

Internal linking

• Homepage links into 6 collection categories + product cards. Reasonable.
• No "pillar" content cluster on legality, education, dosing. All internal links flow product-to-product or category-to-category.
• No breadcrumb schema on product page (verified in HTML grep). Visible breadcrumb exists but not marked up.

Product schema (HARD GAP)

On /products/apples-bananas-2ml-liquid-diamonds the JSON-LD types found are: Organization, Brand, Offer (x7).

Missing: Product, AggregateRating, Review, BreadcrumbList, FAQPage, Sku, Gtin, MPN.

This is the single highest-leverage technical fix. Judge.me has a free schema injector but it appears not enabled or theme-overridden.

Image alt text

• Home: 16 imgs, only 7 with alt text. 9 with alt="". The 7 alts that exist are mostly "Budtender" or empty placeholders; not descriptive.
• Product page: alt text is product name only, e.g. alt="Frog Poison | 2ml Liquid Diamonds". No description of what is in the image (vape device, packaging, etc.).

Product descriptions

• Shopify body_html field is empty for all products (verified via /products.json). Descriptions are rendered by the theme using metafields or hardcoded snippets.
• This means: Shopify product feed exports (Google Merchant, Facebook catalog, AI shopping engines) get blank descriptions. Disastrous for AI commerce surfaces (ChatGPT shopping, Perplexity Shopping).

Pri 1 on-page fixes

---

3. E-E-A-T Signals

Founder and About

• About introduces "The Budtender Guru" (anonymous) and "The Ganjier" (Shirley, no surname). No photo, no LinkedIn, no credentials. ~400-500 words.
• Richard Creagh's 25-year medtech background is invisible on the site. Single biggest E-E-A-T lever to surface Tuesday.

Trust and compliance

• Age-gate blocks site (baseline good).
• Footer covers Medical/Disclaimer, Returns, Shipping, T&Cs, Privacy.
• Medical disclaimer ~280 words, generic, names zero cannabinoids, references zero statutes.
• No HPRA reg, no VAT/CRO, no physical address anywhere on the site. Contact lists email only. For an EU cannabinoid retailer this is a regulatory red flag and trust killer.
• No lab-partners page; CoA link goes to a dir, not a process.
• 2,531 Judge.me reviews carousel + free-ship and 18+ banners. No Trustpilot, no industry certs.

Regulatory posture (HARD FLAG)

Catalogue shows Liquid Diamonds, Live Resin, strain-named SKUs (Sour Diesel, Apples & Bananas), at EUR 80 / 2ml; pricing consistent with hemp-derived synthesised cannabinoids. Disclaimer references zero of: EU Novel Food 2015/2283, Irish HPRA framework, UK Misuse of Drugs Act, German KCanG (Apr 2024), French ANSM HHC ruling (Jun 2023). Several jurisdictions on the language switcher have banned or restricted cannabinoids the store appears to ship. Factually flag on Tuesday, do not advise. Frame: "regulatory clarity that customers AND AI engines look for; also legal hygiene."

Pri 1 E-E-A-T fixes

---

4. AI Ranking Probe (Cite-Likelihood, 0-3)

Methodology: 30 plausible buyer queries to ChatGPT, Perplexity, Google AIO, Claude. Score reflects whether TheBudtender is likely cited based on findable on-site content. Framed as increased likelihood of citation, never guaranteed.

AI-ranking probe top score: 2 (best cases). No query scores 3. Aggregate (sum / max possible 90) = 24/90 = 27% citation-eligibility floor.

Headline: TheBudtender wins only on direct brand and category-with-locale queries; loses every educational, comparative, and regulatory query a curious EU buyer asks an AI engine first.

---

5. Content Gap Analysis

Zero-coverage clusters

• Per-cannabinoid explainers: HHC, HHCP, THCP, THCa, D8, D9, CBN, CBG (each ~1000 words: what / effects / legality table / SKUs).
• Per-jurisdiction legality hubs: IE, UK, DE, FR, IT (each ~1500 words, sourced, dated).
• Format guides: live resin, liquid diamonds, infused pre-rolls, THCa flower, vape pens.
• Dosing guides per format with "start low go slow" framework.
• Condition-led factual pages: sleep, focus, stress, social, creative.
• Comparisons: Daytime vs Evening gummies, Live Resin vs Liquid Diamonds, 1ml vs 2ml.
• Customs/import per jurisdiction; lab process page; beginner guide; glossary.

Headline

244 products, 4 FAQs, 0 blog posts. Product catalogue is mature; educational and regulatory layer is absent. A 24-post 90-day engine ships now: every concern a buyer Googles before purchase currently routes to a competitor or Reddit.

90-day priority order

• Per-jurisdiction legality hub (5 pages)
• Per-cannabinoid explainers (6 pages)
• Format guides (5 pages)
• Comparisons (4 pages)
• Dosing hub (3 pages)
• Founder + lab + trust (3 pages)

---

6. CRO

• Age-gate: functional but generic; no regulatory framing to build trust.
• Hero: "You've found the hidden stash" - brand-voice, no value prop, no ICP signal. Cold buyer wanting "best CBD for sleep" bounces.
• PDP CTAs: single Add-to-cart, no urgency, no inline social proof; 94% 5-star Judge.me ratings are below the fold.
• Cart: free-ship banner good; no exit-intent, no observed abandoned-cart popup; no PDP cross-sell ("pair with batteries" obvious).
• Social proof: 2,531 reviews buried in carousel. Above-fold testimonial strip + schema rating display lifts both SERP CTR and AI citation credibility.

Pri 1 CRO fixes

---

7. Backlinks (Inferable Signals Only)

Site-only signals: affiliate program live, wholesale page targets B2B, social linked (FB/IG/TikTok/YouTube), no press page, no "as seen in" strip, no guest-post outbound, multilingual sitemaps suggest EU targeting but localised PR and EU directory placements are unexploited.

Quick-win backlink plays

• EU CBD/hemp directories (Cannareporter, Leafie, Strain Insider, Hempire).
• Affiliate PR push (Reddit, Discord hemp servers).
• HARO/Qwoted targeting "EU cannabis regulatory expert" for Richard's medtech angle.
• Richard LinkedIn cadence: 1 post/wk, medtech-meets-hemp narrative.

---

Prioritised Fix List (90-Day Plan Anchor)

Pri 1 (Ship in 30 days, foundation)

Pri 2 (Days 31-60)

Pri 3 (Days 61-90)

---

Tuesday Call Opening Order

• The 27% AI citation-eligibility figure (visual punch).
• The schema gap: one config flip unlocks 244 PDPs.
• Regulatory framing: Richard's medtech background bridges current thin disclaimer to a trust hub that wins both regulators and AI engines.
• The 90-day plan above as the deliverable.

Avoid

• Asserting cannabinoid legality anywhere. Always factual: "as of [date], [source] indicates [status]."
• Promising guaranteed AI ranking. Always: "increased likelihood of citation."
• Em/en dashes (rule 06). Specific medical claims.

Data Limits

Wayback fetch blocked; site age inferred from product timestamps + Judge.me review IDs. No Ahrefs/Majestic. No Lighthouse/PSI run; CWV is heuristic. Age-gate not authed past via real browser; assumed bypassable to crawlers per Shopify default.

Cross-references

• /Users/donal/agency-operator/deliverables/oleo/ (existing handover, presentation, growth-plan, ai-ranking, technical-seo, schema folders; this audit supersedes earlier v1 fragments)
• Rules 05, 06, 13

TheBudtender - AI Ranking Deep Audit v1

Methodology

50 queries x 4 platforms = 200 cells. Hypothesised 0-3 citation likelihood, not live API. Anchored in on-site reality from full-audit-v1.md: 244 products, 0 body_html, 0 Product / AggregateRating / Review schema, 4 FAQs, 0 blog posts, 0 jurisdiction pages, 0 cannabinoid explainers, founder invisible, generic disclaimer, 2,531 reviews not schema-surfaced.

Rubric: 0 = no cite path. 1 = weak (thin PDP, brand mention). 2 = moderate (brand + locale, FAQ touch). 3 = strong (dedicated, sourced page).

Platform stance: ChatGPT = trust list + Bing, penalises thin PDPs, heavy cannabis filter. Perplexity = live web, most permissive for retailers. Google AIO = schema + rank biased, harshest on thin PDPs, heavy YMYL filter. Claude / Gemini = safety-tuned, hedges on cannabis, cites governmental.

Jurisdictions: IE, UK, DE, FR. Cannabinoids: CBD, HHC, HHCP, THCP, CBG, CBN.

---

Citation eligibility floor (current state, hypothesised)

Per-platform hit rate

Per-intent hit rate (sum across 4 platforms, max per query = 12)

Per-jurisdiction hit rate (commercial + regulatory queries only)

Ireland scores highest because of brand + locale match and a small set of "Ireland" mentions in metadata. UK is partial (multilingual sitemap, no UK content). DE and FR are effectively zero outside core commercial queries.

Per-cannabinoid hit rate

CBD scores highest within cannabinoids because it is the only one with even partial regulatory clarity in EU markets and the only category where the site has any product-density advantage. HHCP and THCP are effectively invisible.

Headline

The 4-platform floor is ~71 / 600 = ~12%, materially below the 27% from the 30-query probe. The 30-query probe averaged across an unspecified platform stance; the 4-platform breakdown shows Perplexity and IE queries inflate the avg while AIO, Claude / Gemini, regulatory, and DE / FR are near-zero.

---

The 50 queries scored

Note on totals: the per-cell totals across the 50 rows above add to 74 by my final tally. The platform-summary table earlier in the doc reflects the same data rounded into per-platform sums of 17 / 28 / 14 / 12 = 71. Honest reading: anywhere between 71 and 74 cells out of 600 is the credible band for the current floor. Both numbers round to ~12% citation eligibility, materially below the 27% headline from the 30-query probe.

---

Top 10 highest-leverage gaps

Queries where TheBudtender is closest to citation and missing one or two specific signals. The right ship flips 0 or 1 to 2 or 3 across multiple platforms.

Shipping #1, #2, #4, #7 plus the schema flip across all PDPs is roughly 10 days of work and should lift the floor from 12% toward 22-25%.

---

Lowest-leverage queries (skip in 90 days)

Where governmental / mainstream-news authority owns the moat and AI engines will not cite a retailer in 90 days regardless of effort. Build the legality hub anyway for on-site trust, but do not forecast AI lift here.

---

Citation lift forecast post-Phase 1

Phase 1 ships the 10 wins from full-audit-v1.md Pri 1: schema injection, body_html backfill, founder page, jurisdiction legality hub, footer / Org schema, hero rewrite, cannabinoid explainers, format guides, lab process page, title-tag rollout + directory push.

Forecast (increased likelihood of citation, not guaranteed):

Drivers: schema flip lifts every commercial query +1 cell on Perplexity + AIO. Cannabinoid explainers + legality hub clear the educational + 4 of 12 regulatory rows. Founder + trust hub lifts brand cluster from avg 4.5 to 7-8.

Risk-adjusted: schema + founder only -> 12% to 17-19%. Full Pri 1 ships clean -> 24-28% is the credible band. Cannabis safety filters on Claude / Gemini cap their lift regardless. Frame as "material movement on Perplexity and AIO, partial on ChatGPT, capped on Claude / Gemini."

---

What this means for deck slide 4

Slide 4 currently shows 17 / 60 = 28%. That came from the 30-query single-score probe and overstates the floor because it averaged an unspecified platform stance and excluded the harshest engines (Google AIO + Claude / Gemini).

Update slide 4 to:

• Replace "17 / 60 = 28%" with "~71 / 600 = ~12% across 4 AI engines x 50 strategic queries".
• Add per-platform bar: ChatGPT 11%, Perplexity 19%, Google AIO 9%, Claude / Gemini 8%.
• Add 12-week forecast band (24-28% post-Phase 1) as right-side comparator. Story flips from "+28% upward" to "we triple the floor in 12 weeks."
• Caveat: "Hypothesised citation likelihood based on on-site signal fit. Re-probed live at week 4 and week 12."

This is more honest, sharpens Phase 1 ROI, and gives Tomas / Richard a re-probe milestone for weeks 4 and 12.

---

What to avoid

• Asserting cannabinoid legality anywhere on the deck or the audit. Always factual: "as of [date], [source] indicates [status]."
• Promising guaranteed AI ranking. Always: "increased likelihood of citation."
• Em / en dashes (rule 06). Verified zero in this file.
• Counting Reddit, Healthline, Cannareporter, EFSA, ANSM, gov.uk, etc. as competitors of TheBudtender (rule 09). They are content moats, not retailers.

Data limits

• Citation cells are hypothesised, not API-probed. A live 50-query, 4-platform run is the next step; budget 200 API calls + ~$15 spend.
• Cannabinoid market shifts fast on regulatory queries. Re-score the regulatory cluster monthly.
• Slide 4 update should land before Tuesday's call.

Cross-references

• full-audit-v1.md - the 30-query parent
• master-deck-v1.html - slide 4 update target
• Rules 05, 06, 09

TheBudtender.com Market Dive v1

Prepared for: Tuesday 13 May 2026 call with Richard and Shirley Creagh.

Goal: Surface every business insight from the IE/UK/EU cannabinoid ecom market that the competitor table and persona docs do not already cover. Trends, regulation, buying behaviour, channels, pricing, sources, and wedge offer hypotheses.

Method: DataForSEO Google Trends (4 geos, 5 years, ad-hoc puller) + 14 web searches + targeted source reads. Reddit anonymous endpoint hit a 429 mid-pull, so qualitative buyer voice was reconstructed from web search summaries of r/CBD threads and Trustpilot reviews of budtender.ie and 8 UK competitors.

Author: Alex (orchestrator).

Status: v1 draft. All numbers cited. Inferences flagged.

---

Executive summary (read this first)

Five things matter for Tuesday.

• The HHC market collapsed across Europe in the 90 days before this call. Ireland banned HHC under the Misuse of Drugs Act 1977 on 29 July 2025. Netherlands placed HHC, HHCP and THCP on List I (same schedule as heroin) on 28 January 2026. France issued a fresh ANSM arrêté on 16 January 2026 covering HHC and 10-OH-HHC. Germany extended NpSG to derivatives in December 2025. Sweden finalised its ban in December 2025. The UN Commission on Narcotic Drugs scheduled HHC internationally; the decision entered force 6 December 2025. TheBudtender.com still lists HHC, HHCP and THCP products and ships across IE, UK and EU. Richard already knows this. Shirley runs market trend analysis. They are 100% expecting us to address it. Pretending it is not happening will end the call.

• CBD demand in IE/UK is flat-to-declining on Google. CBG, CBN and the wellness compounds are the next leg. "CBD oil" UK trend down 8% YoY (mean recent 6mo 22.8 vs prior 24.8). "CBD ireland" down 7%. "HHC" UK down 4%, IE down 61% (because of the ban). But "CBD gummies" UK up 33% YoY. "CBD shop UK" up 112%. "THCP" UK up 37% YoY. "CBG" UK is flat-mature with peak July 2025. The growth is shifting from CBD-as-substance to CBD-in-format and from CBD to specialised cannabinoids (CBN sleep, CBG focus, plus the HHC/THCP grey-zone wedge that just narrowed).

• Repeat-purchase economics are the actual moat in CBD ecom, not acquisition. CBD industry repeat-purchase rate is 36.2% (vs 21% ecom average). Repeat customers generate 78.4% of CBD brand revenue. CLV $588. Average days between orders 61. AOV $129. This means every dollar TheBudtender spends on SEO that does not also lift retention is half-spent. The wedge offer should hit acquisition AND retention, not just rankings.

• AI search is the deliverability story that GEO/AEO uniquely solves. CBD is blocked from Google Shopping. Facebook blocks cannabis creative. Instagram shadow-bans. Reddit is hostile to vendor self-promotion. Email deliverability is fragile (every mainstream ESP has cannabis content rules). Affiliate networks are limited. Organic search is already 60-70% of category traffic by default; AI search citation is the next 10x because it inherits authority signals while bypassing the same gatekeepers that block paid. This is the single best framing for why Richard should pay us, not a generic SEO firm.

• Richard is operating in a cannabinoid-stack arms race with three unseen competitors: Reddit, Trustpilot, and AI engines. Buyers do not start at thebudtender.com. They start with "best CBD oil UK 2026" and "is HHC legal Ireland 2026" and "buy HHC alternative UK." Whoever shows up in those answers wins the click. Right now ChatGPT and Perplexity cite Releaf, Evopure, BRITISH CANNABIS, Cannigma, Project CBD, Leafly, and Prohibition Partners. TheBudtender shows up nowhere. The wedge: get TheBudtender into the answer set inside 90 days using a content + entity + schema play that does not require new product launches or paid ads.

---

1. Market sizing

UK CBD market

Growth narrative: Volume growth has slowed since the 2021 peak. Value growth continues because higher-strength SKUs (1500-3000mg oils, sleep stacks) are pulling AOV up. The £15bn projection in Botanical Garden is an outlier that bundles medical cannabis. Treat £1bn as the credible 2025 UK retail CBD number.

Ireland CBD market

IE narrative: Small absolute market (60-80m USD), low growth, hemp-derived dominant, almost entirely online (no Boots-equivalent CBD aisle). Trustpilot lists ~5 visible IE-domiciled CBD brands of which budtender.ie is the most visible. Two implications. (a) Whoever owns the top 50 IE-specific keywords owns most of the addressable market. (b) The IE TAM alone does not justify a £5k+/mo retainer unless the SEO play extends into UK and EU.

EU CBD market

Hemp-derived novel cannabinoid (HHC, HHCP, THCP) market

Sizing: No public credible market-size figure exists for the European HHC/HHCP/THCP retail market. EUDA / EMCDDA flagged HHC as "psychoactive substance of concern" in 2022-2023, but their report on semi-synthetic cannabinoids explicitly states the retail market size is unknown. This is itself a finding: TheBudtender's HHC line operates inside an information vacuum where regulators do not publish numbers and most competitors avoid disclosure.

What we can infer: Czechia (population ~10.5m) was the largest open HHC retail market in 2023-2024 before the Psychomodulatory Substances Act, with hundreds of physical retailers. Industry estimates put peak EU HHC retail value at €100-300m (broad range, treat as inference only). Post-bans (Germany, France, NL, IE, CZ, AT, SE, IT, ES, PL all closed Dec 2024 - Feb 2026), the remaining open retail markets are Belgium (pharmacy/permit only), Denmark (permit), Portugal (treaty-bound, enforcement active), and partial Switzerland. The HHC retail TAM in countries TheBudtender currently ships to has fallen by an estimated 80%+ in the past 12 months.

---

2. Google Trends data (5-year, weekly, DataForSEO)

Pull executed 8 May 2026. Tool used: /tmp/cannabis_trends.py (custom puller reusing agency-operator/.env auth + DataForSEO keywords_data/google_trends/explore/live). The standard tools/trends-tracker/pull_trends.py reads from a fixed keyword universe CSV so a custom puller was needed for cannabis-specific keywords. Status: worked clean, all 12 keyword × geo combos returned data.

Scale 0-100 (Google's relative interest index, peak in window = 100).

CBD core terms

Reading: UK CBD core demand peaked Oct 2021 and has been bumping along a flat plateau since. The "+33%" on "cbd gummies" UK is real and meaningful; gummies are taking format share from oils. Germany's "cbd oil" recent +78% suggests Germany is mid-recovery from a 2023-24 dip, likely tied to KCanG passing in April 2024 normalising cannabis conversation. France's +62% is the same pattern post 2022 court ruling that overturned the original CBD flower ban.

Novel cannabinoid terms

Reading:

• IE HHC -61% is the regulatory cliff. The peak in July 2025 is exactly when the ban entered force - searches surge ("is it banned?", "where can I still buy?") then collapse as supply closes.
• UK THCP +37% is the standout signal. TheBudtender already sells THCP. THCP is currently captured by the UK Psychoactive Substances Act 2016 in legal interpretation, but the search trend says buyers are increasingly looking for it. This is a defensive content opportunity (educate why TheBudtender does or does not ship THCP to UK) more than an offensive one.
• CBG UK -8% but absolute peak July 2025 = mature category, CBG is over the novelty hump. CBG is a solid evergreen pillar.
• CBN sleep returned no series in Google Trends for any of the four geos (data too sparse). This is itself an opportunity: anyone publishing comprehensive UK/IE CBN sleep content right now is competing with very thin SERP supply.

Buying-intent terms

"buy cbd uk" UK collapsed 65% YoY (peak Oct 2024 = 100, latest = 4). Buyers are shifting from "buy CBD UK" to "best CBD oil UK," "CBD shop UK," "CBD gummies UK" - the language has moved from raw transaction to research-first. Implication for SEO: TheBudtender should not chase "buy" terms; they should own "best," "review," "compare," "is X legal," "which X for [outcome]."

Seasonality

The Trends data shows a Q1 peak each January every year for "cbd oil" UK and "cbd gummies" UK, consistent with Numerator's Dry January 2026 report where 21% of Dry January participants substitute cannabis or CBD for alcohol. Cannabis tincture sales rose 57% during Dry January at one US retailer (cited in Mile High Labs). The single biggest commerce event for hemp ecom in IE/UK is the December-to-January Dry January build, then a softer secondary peak around early September (back-to-routine).

12-month forecast outlook

Combining the trends + regulatory data:

• CBD core: flat to -5% in IE/UK, +20-40% in DE and FR (recovery curve)
• CBD gummies and CBD topicals: +20-40% YoY across IE/UK
• HHC: -50%+ in IE/UK (already happened); -70%+ in remaining EU markets as bans stack
• THCP: +30-50% in UK (interest), but TheBudtender's actual UK shipping window is regulatory-fragile
• CBN: pre-discovery in Trends; assume 5-10x search volume growth over 12 months as US-driven content reaches IE/UK SERPs
• CBG: flat in UK, growing in DE

---

3. Buying patterns

Demographics (UK)

• 6m UK adults have used CBD; 1.3m active spenders (CMC)
• Highest recency 25-34 (15%) and 18-34 generally; trial peaked >55 historically but younger cohorts are the growth driver
• Female bias on use frequency (8.04/mo vs 7.64 for males); male bias on lifetime trial (34% vs 25%)
• Higher use in Wales and Northern Ireland
• 54% buy primarily online vs 46% in-store

Why buyers buy (UK consumer survey)

• 36% sleep
• 35% pain
• 32% anxiety
• General wellbeing (overlapping)
• Mental health management (overlapping)

This is the content map. Sleep is the #1 category. CBN sleep gummies are the most underserved high-intent category in IE/UK SERPs as of May 2026.

When buyers buy (cross-category ecom inferences)

CBD-specific time-of-day data is not published. UK ecom in general peaks 8-9pm with sales building from 3pm and dropping after 10pm (The Drum). Dry January peak weeks: last week of December and first 3 weeks of January. Q1 evening shopping is the right framing for any TheBudtender activation.

Cart and conversion behaviour

Read: TheBudtender almost certainly has retention rates above the 21% ecom baseline simply because CBD as a category does. The actionable lift is taking 36% retention to 50%+ via subscription (currently absent or thin on the site, per the truncated catalogue read). Each 1pt of retention is a multiple of acquisition spend.

---

4. Regulatory map (IE, UK, EU + 5 notable countries)

Status as of 8 May 2026. Source where dated: linked at row.

International overlay: UN Commission on Narcotic Drugs scheduled HHC internationally in March 2025; entered force 6 December 2025. EFSA published a provisional CBD safe daily intake of ~2 mg/day on 9 February 2026 - this is below the UK FSA's current 10 mg ADI and could force a UK alignment downward. Watch this for Q3-Q4 2026.

Expected change next 12-24 months:

• UK FSA first formal CBD novel food approvals: Autumn 2026. The market goes from "validated, awaiting approval" to "approved + enforced." Brands without validated applications get delisted from England + Wales.
• EU-wide harmonisation of CBD novel food via EFSA's 2 mg daily intake recommendation (provisional). If adopted, UK 10mg ADI may be challenged.
• Ireland MCAP eligibility expansion (Allwright review reports 2026) - relevant for Oleo, not directly TheBudtender, but reframes the regulatory mood music.
• Belgium and Switzerland are the most likely next-shoe-to-drop on HHC.
• Possible CBN-specific regulatory framework if EFSA flags it. CBN is a degradation product of THC; some regulators may treat it differently than CBD.

---

5. Authoritative sources for AI engine citation

These are the sources ChatGPT, Perplexity, Google AI Overviews and Claude pull from when answering CBD/cannabinoid queries for IE/UK/EU. Content built referencing these sources earns citation share.

Tier 1 - cited routinely (build content that mirrors and cross-references)

• Prohibition Partners - the European Cannabis Report and CBD Consumer Report are the most-cited industry research artefacts in EU cannabis AI answers
• Cannabis Health News (UK)
• Business of Cannabis (UK + global)
• The Cannigma (US/global, regulatory + science)
• Project CBD (US, science-heavy, EU regulators read it)
• Leafly (US/CA dominant, but high citation share globally)
• Weedmaps (similar to Leafly)
• European Industrial Hemp Association (EIHA)
• European Union Drugs Agency (EUDA / formerly EMCDDA)
• UK Food Standards Agency (FSA) - novel food register
• HPRA Ireland - controlled drugs and MCAP
• Releaf (UK) - heavy education content, frequently cited
• Centre for Medicinal Cannabis (CMC)
• Association for the Cannabinoid Industry (ACI)
• Bedrocan (clinical, mentioned in Richard's MCAP context)

Tier 2 - peer-reviewed and clinical (link from your content)

• Sleep Medicine Reviews (Dec 2025 meta-analysis on cannabis + sleep)
• Frontiers in Pharmacology (CBD anxiety RCTs)
• Journal of Cannabis Research
• British Journal of Pharmacology
• PubMed Central PMC
• ScienceDirect for HHC harms research (UH Galway 2025 study cited here)
• Lancet Psychiatry (cannabis and mental health studies referenced in Irish HHC ban)

Tier 3 - directional and trade press

• BusinessOfCannabis, CannabisIndustryJournal, Cannabis Tech
• HempToday
• Hempoint (international hemp news)
• Cannabist EU
• NutraIngredients (UK food regulator coverage)
• Forbes Cannabis - high domain authority means it's cited even when content is thin
• Medical News Today CBD section - mainstream health authority
• Healthline CBD section - top UK consumer SERP citations

For TheBudtender's content strategy: every pillar piece should cite at least 3 of Tier 1 + 1 Tier 2 (clinical) source. Schema for these is Article with citation markup. AI engines weight citation graphs heavily.

---

6. User buying anxieties and qualitative voice

Tool status

reddit_search.py failed. The anonymous Reddit JSON endpoint returned HTTP 429 (rate-limited) on first call. The tool supports a --auth script_app flag but the PRAW credentials in .env were not verified inside this session. Workaround used: WebSearch summaries of r/CBD, r/UKHHC threads + Trustpilot review aggregations of budtender.ie, nuleafnaturals.com, britishcannabis.org, cbd.co.uk and 4 others. Fix path: verify Reddit script-app creds and rerun with --auth script_app --save-to-vault to get raw post bodies and comment threads.

Top 10 anxieties / questions buyers ask before purchasing CBD or hemp products

Synthesised from web search summaries of Reddit (r/CBD, r/UKHHC) and CBD-buying-guide articles; Trustpilot review patterns; YouGov UK CBD edibles consumer report.

• "Is this brand legit?" (lab testing / COA) - the dominant trust question. Buyers want a Certificate of Analysis batch-matched to their bottle, posted publicly with a QR or product-page link. No COA = scroll past.
• "How much should I take? I am new to this." - dosing anxiety is universal among first-time buyers. UK FSA 10mg/day cap is a practical benchmark; full-spectrum vs isolate confusion is recurring.
• "Will this make me high / fail a drug test?" - especially among UK professional buyers (driving, employment) and parents.
• "Why is this £80 when the competitor is £30?" - price-anchoring is severe in CBD because mg/£ varies 9x across the market (1p/mg to 9p/mg per for the Ageless).
• "Will it actually work for [my specific issue]?" - sleep, anxiety, pain are the top three; chronic conditions (fibromyalgia, IBS, MS) are the deeper pool.
• "Is HHC / HHCP legal where I live? Will I get the package?" - especially acute IE/UK after the bans. Customs seizure fear is real and explicit on r/UKHHC.
• "How long does shipping take and is the packaging discreet?" - shows up in Trustpilot 5-star reviews repeatedly as the bar.
• "What if it does not work? Refund policy?" - because the product effect is subjective.
• "Is this full-spectrum, broad-spectrum, or isolate? What is the difference?" - the consumer education baseline gap.
• "How does this compare to [Releaf / Blessed CBD / Evopure / NuLeaf / Lazarus Naturals]?" - direct competitor comparison queries are heavy SERP intent.

Top 10 complaints about competitors (drawn from Trustpilot of UK + IE CBD vendors)

• Wrong product shipped, customer expected to pay return shipping
• Inconsistent product potency batch-to-batch (esp. flower, hash, gummies)
• Website "Add to Cart" or checkout broken (recurring NuLeaf and budtender.ie complaint)
• Customer service responses canned ("clear cache and cookies") rather than addressing issue
• Ill-fitting droppers / leaking bottles
• Excessive plastic packaging (Gen Z/Millennial complaint)
• Tamper seals missing on edibles (recurring; UK FSA does not require, but consumers expect)
• Sudden geographic shipping changes with no warning
• "Hash described as kief" / product-grade misrepresentation (specifically called out in budtender.ie Trustpilot reviews)
• Slow refund processing on returned items

Specific TheBudtender Trustpilot signal

From the budtender.ie Trustpilot listing: a mix of "gold standard in Ireland" 5-star reviews and a notable 1-star pattern around "hash described as kief" / inconsistent potency / website checkout failures. Implication: trust signals (COA visibility, lab partner branding, batch-search tool on the site) would close the most-common complaint and are an easy CRO + AI-citation win.

---

7. Pricing intel

CBD oil 30-day supply (UK retail)

Range: 1p/mg (low-end value brands) to 9p/mg (premium).

Median UK price for 1000mg 30-day supply: £35-40.

Premium tier: £55-70.

Average bottle MOQ: 1000mg / £30 / 30-day.

Sleep gummy bottle (CBD or CBN, 30-count)

US/UK aggregated (no UK-only public dataset on gummies). Range £20-£60 per 30-count bottle. Sweet spot £30-£40. CBN-stacked gummies (CBN + CBD + low-dose melatonin) are the format converging.

HHC vape (1ml)

Pre-bans, EU retail HHC vape (1ml) ranged €25-€60 depending on strength and brand. Post-bans, supply is collapsing across EU; remaining markets (Belgium permit, Portugal grey, Spain grey) have prices firming upward as supply shrinks. Not a useful anchor for TheBudtender's UK or IE positioning given the legal exposure.

Where TheBudtender sits

Public catalogue read of thebudtender.com shows pricing from €0 to €4,920 (high end is likely vapes / bundles). Without scraping the full SKU list, the inference is TheBudtender positions premium, with branded vape hardware (Pax, Puffco) anchoring the upper end and Colorado-supplied hemp products at mid-to-premium. This matches the About page voice ("premium," "zero compromises").

---

8. Channel intel

CBD ecom is structurally cut off from most paid channels. The default channel mix tilts heavily organic. The mix below is industry-typical for a UK/IE hemp ecom brand, not a TheBudtender measurement.

Implication: SEO + content + AI search is not one channel of many. It is the channel. Anything that improves organic + AI citation is multiplicative; anything that depends on paid acquisition will hit ceilings fast. This is the strongest argument for a content-and-entity SEO retainer.

---

9. Wedge offer hypotheses (ranked)

Five wedge concepts. The wedge has to (a) get Richard to YES inside one call, (b) create proof inside 4-8 weeks, (c) survive the regulatory headwinds in Section 4, and (d) compound rather than commodity-rank.

Wedge 1 - "AI Citation Audit + 90-day Citation Sprint" (RANKED #1)

The hook: in a category where paid is blocked and SEO is saturated, the next 10x is AI engine citation share. We measure where TheBudtender currently appears in ChatGPT, Perplexity, Claude, Google AI Overviews across 50 IE/UK cannabinoid prompts. We deliver the audit (free or low-cost as part of the proposal). Then a 90-day sprint with monthly citation lift reports.

Why Richard: (a) hits his "do not pitch SEO 101" hot button - this is post-SEO. (b) Shirley does market trend analysis - this is the trend. (c) measurable in weeks, not months. (d) defensible against a generic SEO agency selling backlinks. (e) survives every regulatory shift because content-driven.

Why TheBudtender wins: existing brand positioning is premium + Colorado-sourced + cannabinoid-wellness, which is exactly the editorial voice AI engines reward. The site already has high-quality content; what it lacks is entity density, schema, citations to Tier 1 sources, and reciprocal mentions on Tier 1 properties.

Pros: novel, hard to copy, retainer-extends naturally, ties to Donal's existing AI ranking offer.

Cons: AI citation measurement methodology must be tight or it looks like vapourware.

Pricing anchor: £4-6k/month with a £1.5-2.5k audit upfront, 6-month minimum.

Wedge 2 - "Sleep Stack SEO Pillar" (RANKED #2)

The hook: CBN sleep is pre-discovery in Google Trends UK (no series). Sleep is the #1 buying reason in the CMC consumer survey (36%). TheBudtender already stocks CBN-relevant SKUs. We build a definitive UK + IE sleep-stack content pillar (15-20 connected pieces), each schema-marked, each citing Tier 1 sources, each linking to TheBudtender SKUs. Target: rank #1 for 30+ sleep + cannabinoid queries within 90 days because the SERP is thin.

Why Richard: specific, measurable, hits the largest single buying-reason segment, immediately tied to existing inventory.

Pros: fast wins, low SERP competition, evergreen.

Cons: narrower than Wedge 1; commodity-able by another agency in 6 months.

Pricing anchor: £3-4k/month for a 90-day sprint, then lift to retainer.

Wedge 3 - "HHC Pivot Content Engine" (RANKED #3)

The hook: the HHC category just collapsed across EU. TheBudtender's HHC SKU listings are now legal-exposure plus traffic-bleed. We help reposition: (a) build a "what to use instead of HHC" content pillar covering CBN, CBG, THCV, full-spectrum CBD; (b) create a regulatory-status-by-country live page that becomes a Tier 1 source itself; (c) migrate HHC-related search traffic to non-HHC SKUs.

Why Richard: addresses the elephant in the room. Demonstrates we read the regulatory map. Saves him exposure he is already aware of.

Pros: uniquely necessary for him; almost no competitor will pitch this.

Cons: awkward to lead with; better as Wedge 1 + Wedge 3 combined.

Pricing anchor: £2-3k/month standalone, £3-5k/month if bundled with #1 or #2.

Wedge 4 - "Trustpilot + COA + Schema Trust Stack"

The hook: Trustpilot reviews flag inconsistent potency, broken checkout, and missing COA visibility as TheBudtender's recurring complaints. We rebuild the trust layer: per-SKU COA pages, batch-search tool, on-page review snippets, schema markup, and a Trustpilot remediation pass. Hits the #1 buyer anxiety from Section 6.

Pros: CRO + SEO + reputation in one wedge.

Cons: less novel; agencies pitch this routinely.

Pricing anchor: £2.5-3.5k/month.

Wedge 5 - "Subscription + Retention Engine"

The hook: CBD repeat-purchase is the moat (78.4% of revenue). TheBudtender appears not to run subscriptions. We design a sleep-stack subscription, a "monthly hemp" curated box, and a flow-based email retention engine. Lift retention from category-baseline 36% toward 50%+.

Pros: highest revenue impact per pound spent.

Cons: crosses out of pure SEO into ecom strategy; risks scope creep; not the wedge Richard expects.

Pricing anchor: £4-6k/month, harder to anchor as "SEO" so reframe as "growth retainer."

Recommended pitch combo

Lead with Wedge 1 (AI Citation Audit + 90-day Sprint) as the headline. Bundle Wedge 3 (HHC pivot content) as the strategic adjacent. Mention Wedge 2 (Sleep pillar) as a fast-proof example deliverable inside Wedge 1. Wedge 4 and 5 are upsells for month 4-6 once trust is earned.

---

Sources cited

UK + EU market sizing: Releaf UK Statistics 2025; Prohibition Partners European CBD Report 2025; CMC / National Health Executive; Mission C; Statista IE; Vendo 2026.

Regulatory: HPRA MCAP; RTE - HHC ban Ireland Jul 2025; Cannabis Health News - Ireland HHC ban; Library of Congress Germany CanG; UK FSA CBD guidance; FSA novel food register; NutraIngredients - UK CBD frozen market; Canapuff 2026 cannabinoid country guide; Cannabisregulations.ai HHC 2026; EUDA semi-synthetic cannabinoids; ScienceDirect HHC Ireland harms 2025.

Consumer behaviour + ecom benchmarks: Metrilo CBD ecom benchmarks; Ringly CBD retention; Justuno CBD ecom 2025; MobiLoud cart abandonment 2026; Growth Suite cart abandonment 2026; The Drum - peak online shopping times; Numerator Dry January 2026; Mile High Labs Dry January; YouGov UK CBD edibles.

Pricing: for the Ageless CBD oil cost; Hemptations; Originals CBD; Evopure; BRITISH CANNABIS / Canabidol; Supreme CBD.

Reviews + buyer voice: Trustpilot budtender.ie; Trustpilot british cannabis; Trustpilot cbd.co.uk; Trustpilot CBD Flower Shop; Healthline best CBD; Medical News Today CBD brands.

AI search + cannabis SEO: stupidDOPE 5W PR Cannabis AI Visibility Index 2026; MG Magazine Schedule III AI visibility; Spokes Digital cannabis SEM 2026; NisonCo cannabis SEO 2026.

Tools used: DataForSEO Google Trends explore/live API (custom puller /tmp/cannabis_trends.py, output /tmp/cannabis_trends_results.json); WebSearch (14 queries); WebFetch (3 source reads). tools/intel/reddit_search.py failed with HTTP 429 on anonymous endpoint and was substituted with web-search summaries of Reddit threads + Trustpilot review aggregations.

---

v1 draft. Donal review for any reframes before Tuesday.

Richard Creagh - Founder Credibility Deep-Dive

Built: 2026-05-08 pre-pitch prep

Cross-property: Covers Budtender, Oleo, truMED, Olio.com.

OOB v2 idea catalogue: Highest-leverage E-E-A-T move; idea #82 (speaking-fee) and idea #84 (Cannabinoid Memo).

Compliance: No medical claims. No prescription-product testimonials. Hemp ecom and MCAP surfaces stay separate.

Framing (Rule 05): "Increased likelihood of citation". Never "guaranteed".

---

1. The Arc - Career Narrative in 6 Chapters

Each chapter contributes a transferable lesson the cannabis play needs.

Chapter 1. Computer Science at MTU and Lowell, Massachusetts (1997 to 2005)

Computer Science at Munster Technological University, then over to Lowell where he co-founded Partners In Europe and won a contract supplying components to Dell Ireland (source: lead profile, oleo.ie/pages/richard-creagh).

What ports to cannabis: Standing up an international ops business from scratch, on someone else's procurement standards. Dell Ireland's vendor bar in the early 2000s was high. The same posture (build to a buyer's spec, not your own) is what Richard will carry into pharmacy-channel selling for Oleo and into platform-grade Shopify ecom for Budtender.

Chapter 2. Creco Trading - first ecom exit (2005 to 2009)

Returned to Ireland 2005 and founded Creco Trading, an early ecom business running three online stores in sporting and healthcare goods. Sold 2009 (source: oleo.ie/pages/richard-creagh).

What ports to cannabis: This is the cleanest credibility anchor for Budtender. Richard has built a multi-channel retail operation through to exit before. He is not a first-time ecom buyer, and a content asset that surfaces this fact ("the operator who built and sold a sporting + health ecom group is now applying that discipline to hemp ecom") changes how journalists, podcasters and AI engines describe the business.

Chapter 3. Applied Medical - National Sales Manager (2009 to 2018)

Joined Applied Medical (US-headquartered medical device manufacturer). Promoted to National Sales Manager within three years. Led the global launch of their Advanced Energy Devices line (source: lead profile, paraphrased from theorg.com).

What ports to cannabis: Clinician-buying psychology. Advanced Energy Devices are sold into surgical theatres on evidence, training, and regulatory clearance, not on price. That selling motion is exactly what Oleo needs into MCAP-registered consultants and what Budtender needs into the wellness-skeptical adult consumer who has been burned by no-name CBD.

Chapter 4. Asensus Surgical - Senhance launch (2018 to early 2019)

Brief stint introducing the Senhance Surgical platform to the Irish market (source: lead profile).

What ports to cannabis: Reading the moment a category is about to break into a regulated market. Senhance was a robotic-surgery system entering Ireland against an entrenched da Vinci footprint; he was the wedge. The same structural read - "this category is coming, the existing rails will not serve it, build the rails" - is the bet under Oleo (MCAP) and Olio.com (post-law-change).

Chapter 5. Oleo Technologies founded - the regulatory grind (Feb 2019 to Nov 2021)

Co-founded Oleo Technologies Ltd in February 2019 with Shirley Creagh (CTO). After a 3-year regulatory effort, Oleo became the first Irish supplier to add Bedrocan and Bedrobinol to the MCAP, in November 2021 (source: bedrocan.com/bedrocan-cannabis-officially-available-in-ireland/, oleo.ie).

What ports to cannabis: The supply-chain craft. Three years of HPRA, Department of Health, customs and Bedrocan documentation to import a Schedule 1 substance into Ireland legally. That is a barrier-to-entry story no competitor on Budtender can match, and it is the story that makes a journalist take his hemp ecom seriously.

Chapter 6. truMED EU Operations and TheBudtender (2020 to today)

September 2020 he co-founded truMED LLC, a US-based digital health platform for bariatric patients (truPRO provider portal, truME patient app), serving as President of European Operations (source: trumed.ai). Runs TheBudtender.com in parallel as the active commercial centre of gravity, plus references to Prague and Malta operations (source: John Coffey meeting notes, inferred). Bootstrapped across all three.

What ports to cannabis: The dual-app architecture. Provider plus patient on truMED is the same shape as prescriber-portal plus OleoCare, which is the same shape as a future Budtender consumer assistant plus operator dashboard. Richard is running one playbook in three verticals. That repeatability is the founder asset that lifts every property at once.

Chapter 7. The Olio.com horizon (parked to law-change trigger)

Reserved domain Richard plans to activate when Irish or UK law shifts to permit a broader medical or recreational cannabis surface (source: business-family-map.md, John Coffey meeting notes). No public surface today.

What ports to cannabis: The "ready when the law moves" narrative. This is the chapter that makes Richard a category-defining figure rather than a vendor. The PR play we run in 2026 should make him synonymous with "the operator pre-positioned for Irish cannabis legalisation".

---

2. Three Story Angles for the Podcast Circuits

Angle A. Medtech veteran builds regulated ecom

Target press: Cannabis Health News (UK), Business of Cannabis (UK), Prohibition Partners (research firm), IMT.ie (Irish Medical Times), Sunday Business Post / Business Plus (Cork business).

Hook line: "Twenty-five years inside US medical devices taught me one thing - regulated categories reward operators who treat compliance as a moat, not a tax. I am applying that to hemp."

Why it works: Cannabis trade press is starved of operators who can talk regulatory pathway in real terms. Most cannabis founders come from cultivation or from cannabis-native ecom. Richard's Bedrocan import story is unusual and quotable.

Angle B. Sales-leader-turned-founder lessons

Target press: Sunday Business Post Cork, Business Plus, Irish Tech News, MTU alumni features, regional Cork tech podcasts (e.g. Cork Tech Voices), Sales Confidence and other founder-sales podcasts.

Hook line: "The hardest skill I took out of corporate sales was reading what a buyer is not telling you. That is the same skill that makes a founder shut up about his roadmap and ship what the market is asking for."

Why it works: Cork has a strong founder-PR appetite for native sons who have done the US route and come back. The Applied Medical National Sales Manager arc is undertold publicly.

Angle C. Building patient-app + provider-portal architecture across three companies

Target press: HIMSS, mHealth Intelligence, Healthcare IT News, Digital Health (UK), Silicon Republic (IE), Irish Health Tech Report, plus podcasts: Healthcare IT Today Podcast, This Week in Health IT, Digital Health Unplugged.

Hook line: "I am running the same dual-app architecture across bariatric care, medical cannabis and hemp wellness. The pattern is the moat, not any single vertical."

Why it works: Healthtech press will engage with a repeatable architecture story when most founders in their pipeline are single-vertical. truMED's truPRO + truME + Oleo's prescriber portal + OleoCare is unusually clean as a case study.

---

3. Eight Outlet Pitches (the wedge offer)

Each pitch is the editor angle plus a 100-word outreach template. Editor names verified to publication where possible; where current editor is uncertain, marked as inferred and the masthead URL is given for Tomas to confirm before sending.

3.1 Cannabis Health News (UK, fortnightly)

Editor: Sarah Sinclair, Editor (verified, cannabishealthnews.co.uk masthead).

Angle: First Irish supplier to add Bedrocan to MCAP, now running hemp ecom alongside, perspective on what the Allwright review needs to recommend.

> Subject: Allwright review - the operator perspective from Ireland's Bedrocan supplier

>

> Sarah, Richard Creagh co-founded Oleo Technologies and was the first Irish supplier to land Bedrocan and Bedrobinol on the MCAP in November 2021. He spent three years on the regulatory grind. He is now running TheBudtender, a hemp ecom shipping across Ireland, UK and EU. With the Allwright review live, his view is unusual: the bottleneck is prescriber base, not patient demand, and the next 18 months will be decided by ops not advocacy. He is open to a 700-word op-ed or a Q+A. Available end May. Best, Tomas.

3.2 Business of Cannabis (UK)

Editor: Alex Khan, Founder + Editor (verified, businessofcannabis.com).

Angle: Five years, 74 patients - what an MCAP supplier learns when the constraint is throughput, not demand.

> Subject: 74 patients in five years - what we learned running an MCAP supplier

>

> Alex, your September piece on Ireland's failing MCAP travelled. Richard Creagh was one of four licensed suppliers across the full five-year window. He has the prescriber-side data on why the programme stalled, and the ecom-side data on what hemp consumers in Ireland are actually buying when MCAP fails them. He is willing to publish a numbers-led 800-word breakdown under his own byline, with charts. Cleaner than the advocacy pieces you usually run, more useful for operators. Let me know if you want a draft. Best, Tomas.

3.3 Prohibition Partners (research firm, content calendar)

Editor: Rob Blanco, Head of Content (inferred from prohibitionpartners.com author bylines; confirm via masthead).

Angle: Contributor for the next European Cannabis Report or a standalone Ireland deep-dive. Operator co-author rather than analyst-only commentary.

> Subject: Ireland operator perspective for the next European Cannabis Report

>

> Rob, Richard Creagh of Oleo Technologies and TheBudtender is a Cannabis Europa London 2023 alumnus and one of four MCAP-licensed Irish suppliers. He is willing to contribute a 1,200-word operator chapter to the next European Cannabis Report covering Ireland MCAP throughput economics, hemp ecom growth from a Shopify with 2,532 verified reviews, and the Allwright review impact map. Operator co-authorship is rare in your reports and reads differently to your analyst voice. We can deliver a draft within ten working days. Best, Tomas.

3.4 Irish Medical Times (IMT.ie)

Editor: Catherine Reilly, News Editor (verified IMT.ie masthead).

Angle: Follow-up to Richard's two April 2023 pieces. Three years on, what Allwright should ask the Department of Health.

> Subject: Three years on - revisiting the MCAP for IMT

>

> Catherine, Richard Creagh wrote two strong pieces for IMT in April 2023 - the cannabis tracking app feature and the "time to expand the MCAP" advertorial. Both still get cited. With the Allwright review live in 2026, he is willing to write a follow-up tracking what changed (very little) and what the ministerial review needs to land if Ireland is to avoid a third lost five-year window. 900 words, his byline, no ad placement, available within two weeks. Best, Tomas.

3.5 Business Plus / Sunday Business Post (Cork business)

Editor: Nick Mulcahy, Editor at Business Plus (verified, businessplus.ie). Sunday Business Post: Daniel McConnell, Editor (verified).

Angle: Cork operator runs three companies in three regulated verticals. Native son + Lowell Massachusetts + back-to-Cork + bootstrapped story.

> Subject: Cork-based operator running three regulated companies, all bootstrapped

>

> Nick, Richard Creagh is Cork-based, MTU graduate, returned from Lowell Massachusetts in 2005, sold his ecom business in 2009 and is now bootstrapping three companies - Oleo Technologies (medical cannabis supplier), TheBudtender (hemp ecom across IE, UK and EU), and President of European Operations at truMED (US digital health). Underexposed Cork founder story. Worth a 1,200-word feature for Business Plus, or a "Coffee with" interview slot. Available in Cork mid-June. Best, Tomas.

3.6 The Cannigma (international cannabinoid wellness)

Editor: Elana Goldberg, Editor in Chief (verified, cannigma.com masthead).

Angle: The compliance line between hemp wellness and medical cannabis, written by an operator running both.

> Subject: Hemp wellness vs medical cannabis - operator perspective from someone running both

>

> Elana, Richard Creagh runs TheBudtender (hemp wellness, IE + UK + EU) and Oleo Technologies (Irish MCAP medical supplier). He is one of very few operators sitting on both sides of the regulatory wall. He is willing to write 1,000 words on how the wellness conversation and the medical conversation overlap and where they must stay separate. Reader-friendly, compliance-respecting, no product mentions. Available end May. Best, Tomas.

3.7 Hempoint (international hemp news)

Editor: Marcin Kowalski, Editorial Lead (inferred from hempoint.cz masthead; confirm).

Angle: Cross-EU shipping playbook for premium hemp - what works, what flags, what is changing in 2026.

> Subject: Cross-EU hemp shipping playbook from an Irish operator

>

> Marcin, Richard Creagh runs TheBudtender, an Irish premium hemp ecom shipping HHC, HHCP, THCP, CBD and CBG into IE, UK and EU. With Czechia regulating HHC in 2024 and France banning it the same year, the cross-EU shipping picture changed fast. He has the operator data on what works post-2024, what ships clean and what gets flagged. Willing to write a 900-word piece for Hempoint. Available June. Best, Tomas.

3.8 Healthcare IT Today Podcast (healthtech bonus)

Host: John Lynn, Founder (verified, healthcareittoday.com).

Angle: Running the same dual-app provider + patient architecture across three regulated verticals. truMED + Oleo + a future Budtender operator dashboard.

> Subject: One architecture, three regulated verticals - guest pitch for Healthcare IT Today

>

> John, Richard Creagh is President of European Operations at truMED (US bariatric care, truPRO + truME) and co-founder of Oleo Technologies (Ireland MCAP supplier with prescriber portal + OleoCare). He is running the same dual-app architecture in two verticals and pre-positioning for a third. That repeatability story is rare on the show and lands differently to the usual single-vertical guest. 35 minutes, available in June at any UTC slot. Best, Tomas.

---

4. Wikidata, Wikipedia and Entity-Strength Play

Goal: get Richard a Wikidata Q-item (low bar, fast win), then qualify for a Wikipedia article (higher bar, multi-month).

Step 1. Wikidata Q-item creation (week 1 to 2)

Bar: Wikidata accepts items for any verifiable real-world entity with a stable external identifier. Richard already has multiple. Required identifiers we can supply:

• LinkedIn URL (linkedin.com/in/richard-creagh-493a28134)
• ORCID (request one if not held - 5 minute setup at orcid.org)
• Company role: P39 position-held (President European Operations, truMED LLC; Co-founder, Oleo Technologies Ltd; Founder, TheBudtender)
• Education: P69 educated at Munster Technological University

Action: Create the Q-item with claims against name, occupation (entrepreneur, businessperson), employer (Oleo, truMED, TheBudtender), nationality (Irish), education (MTU). Each claim cited with a reliable source URL.

Step 2. Build the source corpus (week 2 to 8)

Wikipedia notability requires multiple independent reliable secondary sources. Richard currently has:

• IMT.ie (two pieces, 2023) - reliable Irish trade press
• Bedrocan press release (2021) - primary source, supports notability of the import event but does not count toward Wikipedia GNG on its own
• Business of Cannabis - reliable secondary source if he gets quoted in a non-promotional piece
• Cannabis Health News - reliable secondary source

What is missing: at least two more independent secondary sources of significant coverage (not passing mentions). The 8-outlet pitch programme above is engineered to deliver these. Target three landed pieces by month four.

Step 3. Draft notability statement (week 8)

Draft for Wikipedia review:

> Richard Creagh is an Irish entrepreneur and digital health executive. He co-founded Oleo Technologies Ltd in 2019, which became the first Irish licensed supplier to import Bedrocan and Bedrobinol cannabis products into the Medical Cannabis Access Programme in November 2021. He serves as President of European Operations at truMED LLC, a US-based bariatric care platform. He is a public advocate for the expansion of Ireland's Medical Cannabis Access Programme.

Step 4. Draft Wikipedia article in user-space (week 10 to 14)

Draft published in Richard's user-space sandbox first, never moved to mainspace until citations are bulletproof. Three Wikipedia volunteer reviewers are typical pre-submission to avoid speedy deletion.

Step 5. Mainspace submission and AI training-set capture (week 16 onwards)

Wikipedia mainspace gets indexed by every major LLM training pipeline and is one of the highest-weight sources for entity association in AI answer generation. A Wikipedia article on Richard would increase the likelihood of citation across ChatGPT, Perplexity and Google AI Overviews when his name, Oleo, Budtender, or truMED is queried. (Rule 05 framing: increased likelihood, not guaranteed.)

Risk: Wikipedia editors are increasingly hostile to articles that look like founder-PR. Mitigation - the article must be written from independent reliable sources only, no first-party citations, no promotional language, no product names in headings.

---

5. Founder-Led Content Cadence - 12-Month Plan

Monthly cadence across LinkedIn newsletter, Cannabis Summit speaking, podcast appearances. Volume tuned to a bootstrapped operator who runs three companies.

LinkedIn is the only mainstream platform that allows substantive cannabinoid discussion without ad-policy reprisal, which is why the newsletter centres there. Content ghostwritten by OO, approved by Richard, posted from his account.

---

6. Speaking-Fee Productisation (OOB v2 idea #82)

Three tiers, with a clean trigger condition for each. Speaker page lives at richardcreagh.com or as a /speaking page on a property TBD. Calendly integrated for inbound.

Tier 1. Free - harm reduction and patient-advocacy orgs

Triggers when: Audience is a non-commercial patient group, harm-reduction org, university student society, or non-profit policy event. Examples - Drugs.ie, Mental Health Reform, university debate societies, regional patient meetups.

Why free: Builds the citation surface that supports the Wikipedia notability case. Patient-advocacy testimonials are credibility currency in regulated categories. Zero medical claims, framed as "founder-operator perspective on access" not clinical advice.

Tier 2. EUR 1,500 - industry events and trade conferences

Triggers when: Audience is industry, paid attendance, B2B trade. Examples - Cannabis Europa side panels, Hemp Industry Daily Europe, regional pharmacy chain conferences, MedTech Europe events, Irish Tech Summit cannabis tracks.

Why EUR 1,500: Standard Cork-Dublin range for a 25-year operator with two trade-press bylines. Below that and the price signals lack of demand. Above that without keynote-level credentials and the bookings dry up.

Tier 3. EUR 5,000 - keynote slots and brand-funded summits

Triggers when: Conference offers a keynote slot, or a brand sponsor underwrites the speaker fee. Examples - Cannabis Europa London keynote, Prohibition Partners flagship event, large pharma-sponsored regulatory roundtables, major healthtech keynotes.

Why EUR 5,000: Aligns with Cannabis Europa published keynote ranges (verify against current organiser fee schedule). Provides the price anchor that makes Tier 2 look like the obvious value choice for industry buyers.

Activation

• Speaker page with three tiers visible only at director-of-events permission link, not public (looks too commercial otherwise)
• Calendly with three call types (free intake, EUR 1.5k intake, keynote intake)
• Speaker reel - 90 seconds cut from any landed Cannabis Europa or Irish Cannabis Summit appearance
• Inbound routes through Tomas, who qualifies and books

---

7. Cross-Property Halo Math

How Richard-as-entity lifts each of the four properties individually. Quantified where data supports it; otherwise marked as inferred.

Budtender (hemp ecom, active)

• AI citation lift: Increased likelihood of citation in ChatGPT and Perplexity answers to "best Irish hemp brand" or "premium HHC Ireland" queries when Richard has Wikipedia mainspace article + 5+ reliable secondary sources. Inferred lift: 15 to 30 percent more often surfaced in AI answer generation across IE, UK queries (pattern observed across other comparable founder-anchored ecom brands; not Budtender-specific data).
• Trust conversion lift: 2,532 reviews + named founder with 25-year medtech background + Bedrocan import story changes the abandonment math on age-gate exit. Inferred 5 to 10 percent recovery on age-gated bouncers when founder credibility is surfaced on the homepage and About page.
• PR halo to ecom: each landed cannabis-trade piece generates 200 to 800 referral visits in the first 30 days (inferred from comparable cannabis trade press placements).

Oleo (medical cannabis, on ice but Allwright-reviewed)

• Prescriber confidence lift: Wikipedia article on Richard + IMT.ie continued bylines + Bedrocan supply-chain story is exactly the credibility pack a consultant needs to read before adding MCAP to their prescribing pattern. Cannot be quantified pre-Allwright outcome. Strategic value high.
• Allwright submission credibility: if the founder is a Wikipedia-documented operator with sustained policy advocacy across three years of IMT bylines, Oleo's submission to the Allwright review carries more weight than any other Irish supplier's. This is option-value, not revenue today.

truMED (US bariatric, parallel)

• US healthtech press citation: a HIMSS or Healthcare IT Today podcast appearance built on the dual-app architecture story lifts truMED's US sales pipeline directly. truMED's commercial team (Kelly Ladner, Evan Wooldridge) get a citation asset they did not have before.
• Cross-Atlantic credibility: a Cork-based EU President with a Wikipedia article makes Kelly Ladner's US sales conversations easier. Inferred uplift on enterprise win-rate but not measurable.

Olio.com (parked, law-change trigger)

• Pre-positioning value: founder-led content cadence positions Richard as "the operator pre-positioned for Irish cannabis legalisation". When the law shifts, the brand launches to a journalist contact list and an audience already primed by 12 months of The Cannabinoid Memo. Domain authority on richardcreagh.com or olio-adjacent properties pre-build.
• Option value: difficult to quantify, but in adjacent markets (Massachusetts, Illinois) the operators who pre-positioned to media captured 30 to 50 percent of category mindshare in the first 12 months post-legalisation (inferred from US cannabis press analysis).

---

8. The First 90 Days of Founder Build

What we ship in the first 90 days of a founder credibility engagement. Sequenced for fast E-E-A-T lift, with hard deliverables Richard can see.

Days 1 to 14

• Founder page audit on each of the four properties (Budtender, Oleo, truMED EU, Olio.com placeholder)
• Wikidata Q-item filed (week 1)
• ORCID issued, claims cross-linked
• LinkedIn About rewrite, headline standardised, recommendations refresh
• Photography brief - three photo sets (Cork office, Cannabis Europa speaking still if available, casual)
• The Cannabinoid Memo newsletter scaffold built on LinkedIn (issue 1 drafted)

Days 15 to 45

• Founder page rebuilt on Budtender (live)
• Founder page rebuilt on Oleo (live, MCAP-compliant language reviewed by Shirley)
• Founder page added to truMED EU section (coordinated with Kelly Ladner)
• Olio.com placeholder page with single founder paragraph and email signup
• The Cannabinoid Memo issue 1 published
• Two podcast pitches accepted (target Healthcare IT Today + one cannabis podcast)
• IMT.ie follow-up commissioned
• Wikipedia notability source corpus tracked in a single shared sheet

Days 46 to 90

• Founder-AMA hosted on r/IrishBusiness (verified founder flair) and r/cannabis_co
• Two podcast appearances recorded and published
• Cannabis Health News piece landed (target end of month two)
• Business of Cannabis piece commissioned
• The Cannabinoid Memo issue 2 and 3 published
• Speaker page live (private link, three-tier offer)
• Wikipedia user-space draft started (not yet submitted)
• 90-day review with Richard plus Shirley plus John Coffey, with measurable lift report

Acceptance criteria for day 90

• [ ] Wikidata Q-item live with seven or more claims, all cited
• [ ] At least two published podcast episodes
• [ ] At least one landed cannabis-trade press piece
• [ ] LinkedIn newsletter with three published issues, 500+ subscribers
• [ ] Founder page live on all four properties
• [ ] Speaker page live with at least one inbound booking inquiry
• [ ] Founder-AMA completed on at least one subreddit
• [ ] Wikipedia user-space draft existing with seven or more reliable secondary sources cited

---

9. Risks and Mitigations

Founder-led entity work in regulated cannabis carries category-specific exposure. Each risk paired with a concrete mitigation.

The single risk that needs to be flagged in red on Tuesday's call: ASAI / HPRA scrutiny if hemp founder content and MCAP medical content are perceived to share authorship voice. This is the one risk that could threaten Oleo's MCAP licence directly. Mitigation in place but Richard needs to confirm Shirley reviews every line of cross-property founder content before publication.

---

10. Tomas-Pitches-the-Founder-Play (3-paragraph script)

Use this as the bridge from the Budtender SEO pitch into the wider founder-credibility dimension. Insert after the Budtender Phase 1 numbers are agreed, never before.

> Richard, while we are talking about Budtender SEO and AI ranking, there is a layer we want to flag, no extra cost, that lifts every property you run at once. You are sitting on a founder story that almost nobody in cannabis trade press has - 25 years in US medtech sales, an ecom exit, three years on the Bedrocan import grind, and now running a dual-app digital health architecture across two regulated verticals. Most cannabis founders we look at have one of those credentials. You have all four.

> What that means in practical terms is that the same engine we run for Budtender ranking can lift Oleo's prescriber confidence, truMED's US press footprint, and the eventual Olio.com launch, by treating you as an entity. We file you on Wikidata, build a source corpus from the cannabis and medtech trade press, sequence eight pitches across publications you should already be in (Cannabis Health News, Business of Cannabis, IMT, Sunday Business Post, Healthcare IT Today and others), and stand up a LinkedIn newsletter you can publish through. The whole thing reinforces the SEO and AI ranking work because the AI engines weight founder-anchored brands more heavily.

> We do not charge for this on top of the Budtender retainer. It is the same content engine pulling double duty. The only ask is your sign-off on which podcasts you will record, which speaking slots you take, and Shirley's review on anything that touches the medical surface. Productised, your speaking time becomes a revenue line in itself - we tier it free for advocacy, EUR 1,500 for industry, EUR 5,000 for keynote, you take the booking calls. We can show you the 90-day deliverable map after the call.

---

Cross-references

• Lead profile: /Users/donal/agency-operator/knowledge/leads/oleo/profile.md
• Lead insights v1: /Users/donal/agency-deliverables/oleo/budtender/insights-v1.md
• Business family map: /Users/donal/agency-deliverables/oleo/budtender/business-family-map.md
• OOB ideas v2 supplement (idea #82, #84): /Users/donal/agency-deliverables/oleo/budtender/oob-ideas-v2-supplement.md
• Master deck brief: /Users/donal/agency-deliverables/oleo/budtender/master-deck-brief.md
• truMED bio reference: https://trumed.ai/
• Oleo founder page: https://oleo.ie/pages/richard-creagh

---

Compliance reminder for any chat that picks this up: Hemp-derived ecom (Budtender) and MCAP medical (Oleo) live on opposite sides of a hard wall. Founder voice unifies. Brand voice stays separated. Shirley reviews every line that crosses the medical surface. No product testimonials linked to Richard. Rule 05 framing on every AI ranking claim ("increased likelihood of citation", never "guaranteed").

TheBudtender - Buyer Personas v1

Date: 2026-05-07 Owner: OO (for Oleo / TheBudtender)

Buyer-archetype map for hemp-derived cannabinoid products (CBD, CBN, CBG, HHC, HHCP, THCP) shipping into IE, UK, EU.

---

Methodology

Seven personas drawn from Donal's seed brief, public reporting (Cannabis Health News, Project CBD, RTE), and direct scraping of r/Fibromyalgia, r/ChronicPain, r/insomnia, r/cbdinfo, r/hhcvapes, r/probation, r/ireland, r/AskIreland, r/MedicalCannabis_NI via the in-house reddit_search tool (tools/intel/reddit_search.py).

Quote grounding (v1.1, backfilled 2026-05-08). 24 of 33 quotes are now real Reddit verbatims with subreddit + date + post URL attribution (~73% grounded, up from ~3% in v1.0). 9 remain [hypothesised] where searches did not surface a clean enough verbatim within the persona's exact register, or were rate-limited (urllib 429 from Reddit anon endpoint after ~30 sequential queries). Wholesale / B2B and Connoisseur HHCP-premium queries hit the rate limit; those personas keep more hypothesised quotes than the others. Quotes older than 5 years were skipped. All authors anonymised at the username level.

Material correction since v1.0. HHC was officially banned in Ireland in July 2025 (RTE, 2025-07-29) following mounting psychiatric cases. This breaks Persona 3 (HHC Explorer) for IE specifically and softens Persona 7's IE/UK availability. Persona 3 region adjusted to UK / DE primary, IE removed. Persona 7 keeps IE only as amber-shipping. This was not in the v1.0 brief.

Grounded: market boundaries, products, competitor set, trust-signal hierarchy, IE legality status (HHC banned, CBD legal under 0.2% THC), most quotes. Hypothesised: demographic mid-points, exact channel mix, B2B trade buyer voice (no clean Reddit thread).

---

Persona Snapshot Table

---

Persona 1 - The Sleep-Sufferer

Profile

38-55, mid-to-senior professional, IE/UK suburban. Household EUR 60-120k, partner, often kids. Wakes at 03:00-04:00 wired. Already tried melatonin (fades), valerian, magnesium glycinate, sleep apps, CBD 5% (nothing). Reads The Times, Substack, listens to Huberman or Diary of a CEO.

Trigger event

A bad week: three broken nights, a missed deadline, a row with the partner. Wants something that works tonight, not in six weeks.

Search journey

Google ("best sleep supplement that actually works") -> Huberman/Substack mention of CBN -> ChatGPT ("CBN vs melatonin for sleep maintenance") -> r/CBD + r/Nootropics review search -> product page with dose chart + CoA.

Top 5 queries

• "CBN gummies vs melatonin which is better"
• "CBN dosage for sleep 50mg too much"
• "best CBN sleep gummies UK"
• "does CBN make you groggy in the morning"
• "CBN side effects long term"

Verified quote (u/Potential-Ebb-2573, r/insomnia, 2025-05): "I always fall asleep quickly but wake up 3-4 hours later and have trouble going back to sleep. The CBN gummies work miracles for me. I can always sleep through the night after taking them. It does not make me groggy the next morning either, unlike unisom."

[Reddit: r/insomnia, 2025-05, https://www.reddit.com/r/insomnia/comments/1kusnr4/]

Verified quote (u/Stunning-Speaker7245, r/insomnia, 2025-05): "But unlike sleeping pills or melatonin which I've tried before I don't wake up groggy, I wake up really refreshed. The only thing I'd suggest is to not fight the feeling or else you miss the window."

[Reddit: r/insomnia, 2025-05, https://www.reddit.com/r/insomnia/comments/1kusnr4/]

Verified quote (u/sleepymofo69, r/insomnia, 2025-05): "When I was visiting a doctor, my usual pills of trazodone weren't helping, they switched me to seroquel and doxepin, and these didn't help. I knew in my head I had to try something natural. I went back to trying weed again, and found these 2:1:1 gummies (cbn:cbd:thc), and it was what helped me sleep longer than what I was sleeping. My routine went back to normal and I slept like a baby afterwards."

[Reddit: r/insomnia, 2025-05, https://www.reddit.com/r/insomnia/comments/1kusnr4/]

Verified quote (u/PinkPunk7037, r/insomnia, 2025-05): "They're not a cure-all, but they're able to get me roughly 1-2+ more hours of sleep most nights, which is a win for me."

[Reddit: r/insomnia, 2025-05, https://www.reddit.com/r/insomnia/comments/1kusnr4/]

Buying objections

"Will it leave me groggy for the school run?" / "Safe with my SSRI or blood-pressure med?" / "What if my partner thinks I am taking drugs?" / "If I stop, do I bounce back worse?"

Trust signals

CoA per batch (linked on product page, not buried). Founder photo + story; pharmacist/nurse/sleep-coach credential a bonus. Trustpilot 4.5+ with 200+ reviews. Clear "non-habit-forming" line. Money-back-if-it-does-not-work guarantee.

What converts them

A dose chart ("5mg light, 10mg solid, 25mg deep"). A "first-night results" claim grounded in a 7-day routine. Honest comparison page (CBN vs melatonin vs valerian vs prescription). A paragraph from a named GP/pharmacist who has tried it.

What kills the sale

Stock bong photo on homepage. "Get blazed and chill" copy. No CoA visible. DOB pop-up that fails on mobile. THC mention without "0.0% under UK/IE limit" tag.

Lifetime value pattern

Recurring monthly subscription if it works. 12-24 month retention, EUR 500-1,200 LTV. Evangelises to 1-2 close friends, rarely on social.

Top 3 channels

Google high-intent search ("CBN gummies UK"); Huberman-adjacent UK/IE newsletter and Substack sponsorships; ChatGPT / Perplexity / Google AI Overviews visibility.

Sample product page copy

> Dreamline CBN 25mg + CBD 10mg gummies. Built for people who fall asleep fine and wake at 3am wired. CBN hangs around longer than melatonin, so you stay under instead of bouncing back up. 25mg clean dose with full-spectrum CBD. CoA every batch. No grogginess, no habit, no THC over the UK/IE legal limit. One gummy 45 minutes before bed. Most feel the difference by night three.

---

Persona 2 - The Wellness-Curious

Profile

28-45, urban EU (Berlin, Amsterdam, Lisbon, Barcelona, Paris). Yoga, breathwork, plant-based or flexitarian, Strava 4x a week. Functional Mushrooms tin in the kitchen, Magnesium Bisglycinate on the nightstand. No interest in getting high. Income EUR 40-90k, single or coupled, no kids yet, rents.

Trigger event

Read about CBG as the "mother cannabinoid" or saw a DTC Instagram brand with apothecary aesthetic. Wants a daytime cannabinoid in the stack.

Search journey

Instagram saved post -> Google ("CBG benefits daytime focus") -> 2-3 brand sites compared on aesthetics + ingredients -> Substack or Project CBD long-form -> buys the brand with cleanest label and most credible founder.

Top 5 queries

• "CBG vs CBD difference"
• "CBG daytime focus does it work"
• "best CBG oil EU shipping"
• "non-psychoactive cannabinoids list"
• "CBG dosage morning routine"

Verified quote (u/BeesKneesWellness, r/cbdinfo, 2026-02): "I like CBD best for anxiety and relaxation as needed, CBG in the morning for focus and motivation (also shows promise for digestive issues and microbiome support via the gut-brain axis), and CBN + CBD for sleep."

[Reddit: r/cbdinfo, 2026-02, https://www.reddit.com/r/cbdinfo/comments/1qygmnj/]

Verified quote (u/AddieLarue777, r/cbdinfo, 2026-02): "Half the battle seems to be finding something with proper lab reports and clear amounts rather than just good branding."

[Reddit: r/cbdinfo, 2026-02, https://www.reddit.com/r/cbdinfo/comments/1qygmnj/]

[hypothesised] "I am not interested in THC. I want the plant medicine without the head-change." (r/CBD register; rate-limited before grounding)

Buying objections

"Carrier oil organic and cold-pressed?" / "Where is the hemp grown?" / "Is this greenwashing or do they actually test?" / "Why is CBG three times the price of CBD?"

Trust signals

Apothecary design language (not stoner, not pharma-cold). Sourcing transparency: farm name, country, organic cert, extraction method. Founder story rooted in herbalism, naturopathy, or yoga. CoA per batch, third-party lab named. Glass / refill / low-impact shipping.

What converts them

"Morning + evening" stack page pairing CBG with CBD. 60-second unscripted founder video on why CBG. Named third-party lab with link (not screenshot). Free shipping EUR 50+ with glass-bottle unboxing.

What kills the sale

Bro-y copy, capitalised "CHILL OUT", flame emojis. Plastic dropper bottles. No source country. Hemp grown in China with no detail. MLM or affiliate-aggressive site behaviour.

Lifetime value pattern

Recurring + evangelist. Monthly orders, 2-4 referrals in their wellness circle. LTV EUR 800-1,800 over 18-24 months. One Instagram story tag is worth 50 paid clicks.

Top 3 channels

Instagram wellness micro-influencers (10-50k); Substack sponsorships in functional health, longevity, herbalism; SEO long-form ("CBG vs CBD", "morning cannabinoid routine").

Sample product page copy

> Sunrise CBG 1000mg. Cold-pressed organic hemp oil, full-spectrum CBG from a single farm in Co. Wicklow. CBG is the precursor the plant uses to make every other cannabinoid. We extract it before conversion. One dropper under the tongue with morning coffee. Pairs with our evening CBD as a daily ritual. Lab-tested by Celignis, batch-numbered, traceable to field. Glass bottle, recyclable shipper. EUR 65 / 30ml.

---

Persona 3 - The HHC Explorer

Profile

25-40, UK or DE primarily. NOT Ireland (HHC banned July 2025, RTE). Trades, hospitality, tech, or freelance creative. Reddit-native, dab rig or vape collection, knows terpenes. Pre-2018 was a regular cannabis user; legality and drug-tests pushed them out. GBP 25-60k, single or partnered, urban.

Trigger event

YouTube video, Reddit thread, or friend rec. Wants a Friday night that is not alcohol.

Search journey

Reddit (r/UKHHC, r/HHC, r/Delta8) -> YouTube reviewer (Customs Box, Dabbing Granny) -> Google ("HHC vs Delta-8 stronger") -> Telegram product chatter -> scans CoA + reviews, buys.

Top 5 queries

• "HHC vs Delta-8 vs Delta-9 strength"
• "is HHC legal UK 2026"
• "best HHC vape UK reddit"
• "HHCP vs THCP which is stronger"
• "HHC drug test will I fail"

Verified quote (u/AbsolutelyDireWolf, r/ireland, 2025-07): "I've smoked a good bit of HHC over the last year or two. It's not weed, in a bad way, in that the high isn't as nice and gives me a woeful hangover type feeling the next day. I bought it because I'm old now and don't have a dealer and it scratched an itch."

[Reddit: r/ireland, 2025-07, https://www.reddit.com/r/ireland/comments/1mc9vfp/] (pre-IE-ban; same archetype now sources from UK/DE)

Verified quote (u/notprescribed, r/probation, 2025-12): "Yes. I was using HHC in mega amounts and tested positive for 5 months after I stopped."

[Reddit: r/probation, 2025-12, https://www.reddit.com/r/probation/comments/1pbav29/]

Verified quote (u/Traditional-Swan-130, r/probation, 2025-12): "It is highly likely it will cause you to fail. HHC metabolizes into several compounds, and some of those metabolites are very similar to or identical to THC-COOH, which is the specific target metabolite for standard THC tests. Do not risk it."

[Reddit: r/probation, 2025-12, https://www.reddit.com/r/probation/comments/1pbav29/]

Verified quote (u/Infinite-Capital-182, r/hhcvapes, 2024-09): "Acon are harsh, I tried two different types and I had the worst cough I've had in years. I switched to Budtender and I have to say I'm impressed. I would recommend Blueberry Diesel, Alien O.G and Dosi Kush, also if you're brave try Galactic Gas, there's such a thing as being too stoned."

[Reddit: r/hhcvapes, 2024-09, https://www.reddit.com/r/hhcvapes/comments/1f846j3/]

Buying objections

"Will customs seize my HHC vape?" / "Will I fail a workplace drug test?" / "Is the CoA real or photoshopped?" / "Is HHCP just marketing or actually stronger?"

Trust signals

Subreddit mentions + verified-purchase reviews. CoA with QR code resolving to a third-party lab portal. Customs-cleared shipping language ("discreet, tracked, signed-for, UK warehouse"). Strain names, terpene profiles, percentage breakdowns. Reviews citing specific effects.

What converts them

Comparison chart (HHC vs HHCP vs Delta-8 vs Delta-9: strength, duration, per-country legality). Reviews with photos of the actual cart. Reddit-verified or r/UKHHC trusted-vendor badge if achievable. Prominent discreet-packaging promise.

What kills the sale

"100% legal everywhere" copy (they know it is false). No CoA, fake CoA, or batch-number mismatch. Stock vape images. Slow domestic UK shipping (4+ days). Visa disabled at checkout forcing crypto with no warning.

Lifetime value pattern

Weekly-to-fortnightly when in routine. LTV GBP 800-2,400/year. One bad batch and they switch. Reddit evangelist if treated well, brutal reviewer if not.

Top 3 channels

Reddit (r/UKHHC, r/HHC, r/Delta8); YouTube reviewer sponsorships (Customs Box-style); Telegram + curated Discord.

Sample product page copy

> Strawberry Cough HHC vape, 1ml, 95% HHC distillate. Tested at Eurofins Munich, full CoA on the listing, batch-tracked. UK warehouse, next-day, plain packaging, signed-for. HHC sits about 70% of Delta-9 strength with a cleaner body buzz and lighter comedown. Sativa-leaning, bright and citrusy. One pull if new to HHC, two for regulars. Reorder discount at three carts. Does not ship where HHC is restricted (full list on FAQ).

---

Persona 4 - The Chronic-Pain Seeker

Profile

45-65, IE/UK, often retired, semi-retired, or on disability. Fibromyalgia, lower-back nerve pain, arthritis, post-surgery nerve pain, long-Covid pain, MS, endometriosis. 6-20 GP visits. Tried tramadol, gabapentin, amitriptyline, hated the side effects. Spouse usually involved in the decision. Income often fixed but willing to spend on something that works.

Trigger event

A flare-up week, or a friend at the bowls club / book group mentioned CBD oil.

Search journey

Friend recommendation -> Facebook group (Fibromyalgia Ireland, UK Chronic Pain Support) -> Google ("strongest CBD oil for back pain UK") -> Cannabis Health News articles -> phone or live chat with the brand before buying.

Top 5 queries

• "strongest CBD oil for chronic pain UK"
• "CBD vs CBG for arthritis"
• "is HHC legal in Ireland for pain"
• "CBD oil and blood thinners safe"
• "how long until CBD works for nerve pain"

Verified quote (Cannabis Health News, Kerry Davies, fibromyalgia patient): "As a disabled person and full-time carer, cannabis enables me to support my partner."

Verified quote (u/caldoesstuff, r/Fibromyalgia, 2022-01): "I've been taking CBD oil for my fibro for a few years now and it has significantly helped manage my symptoms. It helps reduce the inflammation I get, drops the background level pain and helps me sleep better."

[Reddit: r/Fibromyalgia, 2022-01, https://www.reddit.com/r/Fibromyalgia/comments/s5dd2f/]

Verified quote (u/DannyPhantomRoss, r/Fibromyalgia, 2023-03): "Not just CBD but all cannabinoids seem to work really well with my body and I can actually function like a human again now that I have my medical card."

[Reddit: r/Fibromyalgia, 2023-03, https://www.reddit.com/r/Fibromyalgia/comments/11v2xst/]

Verified quote (u/judi-in-da-skies, r/Fibromyalgia, 2022-01): "Most commercially available cbd drops are far too weak to address my fibromyalgia symptoms... it took me a long time and a lot of experimentation to find what works for me."

[Reddit: r/Fibromyalgia, 2022-01, https://www.reddit.com/r/Fibromyalgia/comments/s5dd2f/]

Verified quote (u/LongTermSu61970, r/Fibromyalgia, 2022-01): "It is the only way I could go back to work and get regular sleep. I use THC, CBD and CBG, the last cannabinoid is harder to find in a mix as it is newer and specifically for nerve pain."

[Reddit: r/Fibromyalgia, 2022-01, https://www.reddit.com/r/Fibromyalgia/comments/s5dd2f/]

Verified quote (u/lissiebee, r/Fibromyalgia, 2023-03): "I also use it nightly too, but not through the day due to work. Hopefully they'll legalise it in the UK so I don't have to deal with the stigma."

[Reddit: r/Fibromyalgia, 2023-03, https://www.reddit.com/r/Fibromyalgia/comments/11v2xst/]

Buying objections

"Will this interact with my warfarin/statin/antidepressant?" / "Is full-spectrum safe if I get drug-tested for benefits?" / "How long until I know it is working?" / "Will my GP find out and judge me?"

Trust signals

Interactions page + downloadable "talk to your GP" PDF. Real photos of named customers with their condition (with permission). Phone + live chat answered by a human. Founder story rooted in personal pain or clinical career. 30-day money-back guarantee.

What converts them

"Ladder of products" page: start CBD, add CBG, add CBN for sleep, add HHC for severe nights. 60-second customer video on their pain journey. Pharmacist- or GP-endorsed safety guide. Free phone consult before first order.

What kills the sale

"Miracle cure" language. Pages that read like a pharmacy brochure. No interactions info. Checkout that fails on iPad. No named human to call.

Lifetime value pattern

Highest-LTV persona. Once it works, monthly for life + 3 friends referred. LTV EUR 2,000-5,000 over 3-5 years. Pain-community word-of-mouth is exceptional.

Top 3 channels

Facebook groups (Fibromyalgia Ireland, UK Chronic Pain Support, Endo Warriors UK); Google high-intent pain queries; Cannabis Health News content sponsorships + patient case studies.

Sample product page copy

> Relief Plus, CBD 2000mg + CBG 500mg full-spectrum oil. For people tired of being told to take paracetamol. CBD calms the system, CBG works on inflammation and nerve signal. Lab-tested by Celignis. Talk to your GP if you are on blood thinners or antidepressants. Free 15-minute phone consult before your first order. 30-day refund if it does not help. Founded by a former hospice nurse.

---

Persona 5 - The Cannabis-Curious-But-Cautious

Profile

50-70, Ireland-leaning, smaller town or rural. Never bought anything cannabis-related. Maybe smoked once at a wedding in 1978. Catholic-cultural background, cares what the neighbours think. A son or daughter said "Mam, just try the CBD, it helps Auntie Mary." Income EUR 30-60k, often retired, mortgage paid.

Trigger event

A child or sibling brought a bottle home, or a cousin in Holland mentioned it, or a sleep/pain issue is bad enough that pride is losing.

Search journey

Asks the family member who recommended it -> Google ("is CBD oil legal in Ireland") -> RTE or Independent.ie piece -> asks GP next visit (usually "fine, just be careful") -> buys the family member's brand, or whichever looked most respectable on Google.

Top 5 queries

• "is CBD legal in Ireland 2026"
• "CBD for sleep over 60"
• "CBD oil safe with heart medication"
• "where to buy CBD Ireland reputable"
• "is CBD the same as cannabis"

Verified quote (u/eoin_me_money, r/ireland, 2018-11): "A wide range of CBD products are available in Ireland. Just be aware that anyone selling it can't legally advise you on dosage or possible medical advantages of it as it is not classed as medicine in this country (yet)."

[Reddit: r/ireland, 2018-11, https://www.reddit.com/r/ireland/comments/a1py2r/]

Verified quote (anonymised commenter, r/AskIreland, 2024-01): "Cannabis is illegal in Ireland but CBD under 0.2% THC is legal in the EU. Pretty sure any amount is legal. However, if you get caught with it, Garda will still seize it and send for a lab test and will treat it as regular weed until they prove otherwise."

[Reddit: r/AskIreland, 2024-01, https://www.reddit.com/r/AskIreland/comments/19449qj/]

Verified quote (u/Miro_the_Dragon, r/Fibromyalgia, 2021-07): "Start with a very low dose since you never know how you'll react to it, and slowly increase it every few days until you either get the effect you want, or start getting adverse reactions."

[Reddit: r/Fibromyalgia, 2021-07, https://www.reddit.com/r/Fibromyalgia/comments/ord4zm/]

[hypothesised] "My daughter put me onto it. I sleep better and that is enough for me." (Trustpilot Dr Hemp Me register; Trustpilot fetch still blocked)

Buying objections

"Is this legal in Ireland?" / "Will I get high or feel weird?" / "Will the postman know?" / "Is this addictive?" / "What will my GP or sister say?"

Trust signals

IE or UK address + phone on contact page. "Legal in Ireland and the UK" badge. Plain packaging promise. Founder photo that looks like someone they would meet at Mass. RTE / Independent / BBC press logos. No cannabis leaves on the bottle.

What converts them

"First time? Start here" guide in plain English. "What to expect on day one" page that pre-empts every fear. Phone number answered with an Irish or UK voice. 10ml starter bottle so the first commitment is small.

What kills the sale

Cannabis leaf imagery. "High", "buzz", "psychoactive" without immediate context. US-only address. THC mention without "0.0% THC, fully legal here" reassurance. Slang or informal copy.

Lifetime value pattern

60-day decision cycle, 18-36 month retention once converted. LTV EUR 600-1,500. Quiet evangelist: tells 1-2 friends exactly like them, those referrals convert at ~80%.

Top 3 channels

Google search (IE/UK plain-English queries); family/friend referral programme; national press partnerships (Independent.ie, RTE Lifestyle, BBC Health).

Sample product page copy

> Steady, CBD 5% oil, 10ml starter bottle. A gentle place to begin. Five drops under the tongue at night, that is it. CBD is the legal, non-psychoactive part of hemp. It will not make you feel high or show up on a routine drug test. Fully legal in Ireland and the UK. Plain-packaged, posted from Dublin. A real person answers our number. Start small, see how it sits, then decide.

---

Persona 6 - The B2B Trade Buyer

Profile

30-55, owner or buyer at a smoke shop, vape shop, wellness retailer, gym, or barber chain. EU-wide, concentrated in DE, NL, ES, IE, UK. Buys for resale, wants margin, paperwork, reliability. Already has 1-2 suppliers, shopping for backup or upgrade.

Trigger event

Current supplier missed a delivery, raised prices, or had a CoA challenged at customs. Shopping for a backup that holds up.

Search journey

LinkedIn search ("HHC wholesale Europe", "CBD private label EU") -> Google ("HHC wholesale supplier Ireland EU") -> trade shows (ICBC Berlin, Mary Jane Berlin, Spannabis) -> cold email from supplier -> sample order, then volume if quality holds.

Top 5 queries

• "HHC wholesale supplier EU"
• "white label CBD private label minimum order"
• "EU GMP compliant cannabinoid supplier"
• "novel food CBD compliance UK 2026"
• "bulk CBD vapes wholesale Ireland"

[hypothesised] "My last supplier got their batch flagged at the German border, lost three weeks of stock. Never again without proper paperwork." (LinkedIn comment register; Reddit B2B threads rate-limited 2026-05-08; LinkedIn / trade show data not in Reddit corpus)

[hypothesised] "Margin is tight. If you cannot land at 35% wholesale-to-retail, do not waste my time." (trade show conversation register; same source-availability gap)

Tangential ground-truth (u/Bright-Principle6543, r/hhcvapes, 2025-06): "They had COAs on their website but have since removed them, I'd question if they were ever legitimate tbh." [Reddit: r/hhcvapes, 2025-06, https://www.reddit.com/r/hhcvapes/comments/1ll2b8g/] - retailer-side scrutiny of a supplier's COA practice; same dynamic B2B buyers describe.

Buying objections

"Is your CoA accepted by my country's customs?" / "MOQ and sample?" / "Lead time and reorder lead time?" / "Novel-food-compliant for UK CBD?" / "Will you sell to the competitor next door?"

Trust signals

Trade-only login with net-30/60 terms. CoAs from a named EU lab (Eurofins, Celignis, Fundación Canna). Trade references they can call. Retailer logos (with permission) on wholesale page. Account manager who answers WhatsApp + email.

What converts them

Clean wholesale price list (not "request a quote"). 24-48 hour sample turnaround. Exclusivity by city or postcode. White-label MOQ ladder (500 / 1k / 5k). Support assets (shelf-talkers, staff training PDF, social tiles).

What kills the sale

"Contact us for pricing" with no MOQ or band. Sales reply that takes 48+ hours. CoA gated behind NDA. Wrong batch numbers on paperwork. A founder who will not get on a 15-minute call.

Lifetime value pattern

Largest account size, slowest to win, longest to retain. 60-120 day sales cycle. Once in, 24-60 months of recurring orders worth EUR 20k-200k+/year per account.

Top 3 channels

LinkedIn (founder outbound + ads to "smoke shop / vape shop / wellness retailer" titles); trade shows (ICBC Berlin, Spannabis, Mary Jane Berlin, Hemp & CBD Expo UK); cold email with founder voice + sample offer.

Sample product page copy

> TheBudtender Trade. For retailers burned by suppliers who could not produce paperwork. Every product ships with a Eurofins or Celignis CoA matched to batch number. UK novel-food compliant. Customs-cleared paperwork for DE, NL, ES, IE, FR. MOQ EUR 500, reorders from EUR 250. Exclusivity by postcode on request. White-label from 500 units. Net-30 after three orders. Sample pack ships in 48 hours.

---

Persona 7 - The Travelling Connoisseur

Profile

28-50, multi-jurisdiction: digital nomad, location-independent founder, crypto-native, second-home owner. Time across UK, DE, ES, PT, CZ, sometimes Thailand or Mexico. Knows cannabis well, has tried Delta-9, Delta-8, HHC, HHCP, THCP, has opinions. Income EUR 80k-500k+, pays for premium.

Trigger event

Travelling next week, wants product waiting at destination not in checked luggage. Or stash ran out and the local supplier is sketchy.

Search journey

Telegram cannabinoid channels -> niche Reddit (r/HHC, r/CannabisExtracts) -> invite-only Discord -> DM to a brand they have heard of -> buys based on jurisdiction availability and discreet shipping.

Top 5 queries

• "HHCP vape ship to Spain legally"
• "THCP edibles strongest 2026"
• "premium HHC live resin EU"
• "discreet cannabinoid shipping Portugal"
• "best HHCP brand reddit"

Verified quote (u/[anon], r/hhcvapes, 2024-09): "I've tried the Acan Loom ones, the Budtender 2ml live resin ones and the Budtender HHC-P ones. All are good, although the Budtender live resin ones taste more like weed or hash depending on the flavour and get you nicely stoned. The Acan Loom ones can be got for €110 for 2 and they last ages."

[Reddit: r/hhcvapes, 2024-09, https://www.reddit.com/r/hhcvapes/comments/1f846j3/]

Verified quote (u/TimeShock743, r/hhcvapes, 2025-12): "The order will not go through any customs... everything happens within Europe."

[Reddit: r/hhcvapes, 2025-12, https://www.reddit.com/r/hhcvapes/comments/1ppfbdm/]

Verified quote (u/disti_goblin, r/hhcvapes, 2024-07): "Just bring it in your bags and if they ask say it's a CBD pen, they don't care. Worst case scenario it would be confiscated from you."

[Reddit: r/hhcvapes, 2024-07, https://www.reddit.com/r/hhcvapes/comments/1e2dnfs/]

[hypothesised] "HHCP is the only one that gives me a real Delta-9 ceiling. Worth the price." (r/HHC register; HHCP-specific search rate-limited 2026-05-08)

Buying objections

"Ship to my country this week?" / "Is the THCP/HHCP actually dosed at the listed level?" / "Crypto payment for privacy?" / "Real live resin or distillate?" / "Reship-on-seize policy?"

Trust signals

Per-product traffic-light shipping map (green/amber/red). Crypto payment (BTC, USDC via BTCPay or NowPayments). Reship-on-seize policy. Premium photography (frosted live resin, terpene-rich packaging). Founder who shows up in cannabinoid Telegram chats by name.

What converts them

"Ships to your country" geo-detect. Premium tier (HHCP, THCP, live resin) at 2-3x standard, clearly differentiated. Crypto checkout with 5% discount. Store-credit loyalty (not points). Same-day dispatch from EU warehouse.

What kills the sale

"Coming soon" on the premium product they came for. Vague "check your local laws" warning. No crypto option. Slow EU shipping (5+ days). Site that looks like every other HHC clone.

Lifetime value pattern

High AOV (EUR 200-600), 6-12 orders/year. LTV EUR 1,500-4,000+/year. Switches instantly for a better premium product. Loyal to founders, not brands.

Top 3 channels

Telegram (niche cannabinoid channels, founder presence required); invite-only premium Discord; Reddit (r/HHC, r/CannabisExtracts, premium product threads).

Sample product page copy

> Live Resin HHCP Cart, 1ml, 90% HHCP, terpene-rich. The closest legal thing to real Delta-9 in most of the EU. Live resin extracted at -40C, terpenes preserved. Eurofins CoA on the listing. Same-day from Berlin to DE, NL, ES, PT, CZ, FR. Amber-shipping to UK and IE: tracked, signed-for, reship-on-seize within 30 days. Crypto checkout earns 5% off. Founder on Telegram. EUR 65 per cart, EUR 280 for five.

---

Cross-persona patterns

• CoA + founder credibility unlock all 7. No persona converts without a visible, batch-matched CoA. 5/7 convert faster with a real founder face and story.
• Plain packaging is universal. From the 65-year-old in Galway to the connoisseur in Berlin: will the postman know? Solve once on the homepage.
• Dose education beats hype. Personas 1, 2, 4, 5 want the dose chart before they care about the brand.
• Jurisdictional clarity is a moat. Personas 3, 6, 7 will not buy from a brand that fudges where it ships. A traffic-light shipping map is rare and converts hard.
• The founder is the brand. Founder face + story + channel presence outperforms faceless brands by a wide margin.

---

Implications for Tuesday's deck

Phase 1 (0-90 days, addressable now):

• Persona 1 (Sleep-Sufferer). Highest margin, fastest payback. CBN gummies are the wedge SKU. Google + newsletter sponsorships. Most-likely-to-win in 90 days.
• Persona 4 (Chronic-Pain Seeker). Highest LTV, fastest word-of-mouth in pain communities. Facebook groups + Cannabis Health News + a "talk to your GP" guide.
• Persona 5 (Cannabis-Curious-But-Cautious). Most under-served in IE. Every competitor speaks to the connoisseur. None speaks to the 65-year-old in Galway. White-space opportunity.

Phase 2 (90-180 days):

• Persona 2 (Wellness-Curious). Needs a daytime CBG SKU + Instagram-credible aesthetic. Build the brand asset library first.
• Persona 6 (B2B Trade Buyer). Needs wholesale portal, MOQ ladder, white-label SKUs, trade-show presence. 60-120 day sales cycle.

Phase 3 (180-365 days, or deprioritise):

• Persona 3 (HHC Explorer). Reddit-native, brutal on bad batches. Channel cost and reputational risk high. Defer until brand is established.
• Persona 7 (Travelling Connoisseur). Smallest count, highest AOV. Needs premium HHCP/THCP SKU + crypto checkout. Build only if Phase 2 succeeds.

Most under-served by competitors today: Persona 5. Provacan, Dr Hemp Me, BudMother all speak past the 50-70 IE buyer. None has a "first time? start here" path in plain Irish-English.

Best positioned to win in 90 days: Persona 1. CBN gummies are a defined wedge SKU, search intent is high, the channel mix is buildable in 90 days, and recurring-subscription LTV compounds fast. Phase 1 over-indexes here.

---

v1.1 Reddit backfill log (2026-05-08)

Searches that ran (via tools/intel/reddit_search.py, anon mode, --save-to-vault)

Tool status

• tools/intel/reddit_search.py works as expected on anon mode for the first ~10-12 sequential queries within a session. After roughly 30-40 cumulative requests (search + comment fetch counts), Reddit returns HTTP 429 from the JSON endpoint and stays blocked for ~10+ minutes.
• Switching to --auth script_app with PRAW credentials would lift the limit (per the docstring) but that path was not configured in this session.
• Workaround: run the high-priority searches first, then pace remaining queries across multiple sessions, or switch to PRAW.
• One subreddit (UKHHC) returned 0 results, suggesting it may be private, banned, or recently renamed. r/hhcvapes is the live UK/EU HHC sub.

Quote backfill summary

Material correction surfaced by the backfill

HHC was officially banned in Ireland in July 2025 following mounting psychiatric cases (RTE coverage on r/ireland 2025-07-29, 176 upvotes, 202 comments; reinforced in r/MedicalCannabis_NI 2025-08-08). This was not in the v1.0 brief and reshapes:

• Persona 3 (HHC Explorer) cannot target IE. Region updated to UK / DE only.
• Persona 7 (Connoisseur) IE shipping must be amber-status with a clear "ships if you can receive" stance, not a green-light.
• Phase 3 priority on Persona 3 now has a regulatory tailwind in EU (DE, NL, ES, CZ still active) and a closed door in IE.
• Brand positioning note: "thebudtender.ie" Reddit footprint shows TheBudtender was a known IE HHC vendor pre-ban (r/altcanabinoids 2025-05; r/hhcvapes 2024-09 mentions). The pivot off HHC into CBD/CBN/CBG sleep + wellness + B2B is consistent with this regulatory event.

Top 3 most resonant quotes for the discovery deck

• u/Potential-Ebb-2573, r/insomnia, 2025-05 (Persona 1 wedge): "I always fall asleep quickly but wake up 3-4 hours later and have trouble going back to sleep. The CBN gummies work miracles for me. I can always sleep through the night after taking them. It does not make me groggy the next morning either, unlike unisom." - This is the exact 03:00-wired pattern in the persona profile, the exact promise the wedge SKU should make, and the exact comparison set (vs unisom / sleep aids).
• u/sleepymofo69, r/insomnia, 2025-05 (Persona 1 + 4 overlap): "When my usual pills of trazodone weren't helping, they switched me to seroquel and doxepin, and these didn't help. I knew in my head I had to try something natural... I went back to trying weed again, and found these 2:1:1 gummies (cbn:cbd:thc), and it was what helped me sleep longer." - Captures the prescription-fatigue trigger event for both Sleep and Chronic-Pain personas. "Knew in my head I had to try something natural" is the wedge sentence for the homepage hero.
• u/AbsolutelyDireWolf, r/ireland, 2025-07 (Persona 3 / IE pivot): "I've smoked a good bit of HHC over the last year or two. It's not weed, in a bad way, in that the high isn't as nice and gives me a woeful hangover type feeling the next day. I bought it because I'm old now and don't have a dealer and it scratched an itch." - This tells the IE customer journey post-ban better than any positioning we could write. The honest reframe ("I bought it because I'm old now and don't have a dealer") is the language the deck should mirror when positioning CBN/CBD as the legal continuation, not a substitute.

What still needs grounding

• B2B Trade Buyer voice (Persona 6) - try LinkedIn search externally, or PRAW-authed query against r/CBD, r/hempflowers, r/cannabusiness with terms like "wholesale supplier compliance EU".
• HHCP/THCP premium voice (Persona 7) - rerun "HHCP vs THCP", "HHCP review premium", r/CannabisExtracts hot-listings once rate limit clears.
• Wellness-Curious THC-free voice (Persona 2 second quote) - rerun "non-psychoactive cannabinoid wellness", "CBD daily routine no THC" on r/CBD when unblocked.

TheBudtender - Out-of-the-Box Ideas Catalogue v1

Built: 2026-05-07

Purpose: Full out-of-the-box ideas universe for TheBudtender 12-month plan. Top 10 baked into the master deck (Phase 1). Phase 2 ready when budget unlocks. Park list captured so nothing is lost.

Source data: master-deck-brief.md, full-audit-v1.md, competitors-ie-uk-v1.md, path-evaluation-v1.md, Oleo handover.

Total ideas: 62

Top 10 (Phase 1 deck-eligible): see section below

Phase 2 candidates: 15 ideas (separate budget when ready)

Park / nice-to-have: 37 ideas (revisit quarterly)

---

Scoring Key

Each idea is scored on three 5-point scales. Score = sum of all three (max 15).

Lift (build effort): Easy = 5, Medium = 3, Hard = 1

Impact (revenue / brand / citation likelihood): High = 5, Medium = 3, Low = 1

Cost (cash out): Free = 5, under EUR 1k = 4, EUR 1-5k = 3, EUR 5k+ = 1

A score of 13 to 15 is Phase 1 territory. 9 to 12 is Phase 2. Below 9 is park / opportunistic.

---

Top 10 (deck-eligible, Phase 1 of the 12-month plan)

These 10 are the highest-leverage, lowest-friction plays for TheBudtender given the cannabis platform-ban reality, the Judge.me review moat, and Richard's medtech credibility. They show up in the deck as the Phase 1 work plan.

1. Per-batch CoA QR continuity into chatbot (Score 14)

A buyer scans the QR on their pouch, lands on a page that shows the lab cert AND opens a chatbot trained on that exact batch's cannabinoid profile. Lift: Medium. Impact: High. Cost: under EUR 1k. Rationale: turns a compliance asset into a conversion + retention surface no Irish competitor has.

Phase 1: wire QR landing pages to chatbot context; index every CoA in vector store.

2. Cannabinoid education hub on a subdomain (Score 14)

Launch learn.thebudtender.ie as an editorial knowledge layer covering CBD vs HHC vs HHCP vs THCP, condition use cases, dosing, jurisdictional legality. Lift: Medium. Impact: High. Cost: under EUR 1k. Rationale: top of funnel for AI citations and buyer-language SEO without polluting the commerce site.

Phase 1: ship 12 cornerstone articles + Article + FAQ + HowTo schema on each.

3. Founder entity build for Richard Creagh (Score 14)

Wikipedia + Wikidata + LinkedIn long-form + medtech-to-cannabis founder podcast circuit. Lift: Medium. Impact: High. Cost: under EUR 1k. Rationale: increased likelihood of citation when AI engines evaluate brand legitimacy, and gives Oleo / truMED / Olio.com a halo founder.

Phase 1: Wikidata Q-item, 6 podcast bookings, 3 founder profile placements.

4. Sleep / Daily / Recovery bundle architecture (Score 14)

Three named stacks ("Wind Down", "Daily Calm", "Reset") priced at a 15 percent discount vs single SKUs, with a guided quiz routing buyers in. Lift: Easy. Impact: High. Cost: Free. Rationale: AOV lift on existing 244 SKUs, no new product needed, copy-and-quiz only.

Phase 1: build 3 stacks + 1 archetype quiz + Klaviyo flow per archetype.

5. Quiz funnel (Sleep / Anxiety / Pain / Daily Wellness archetype) (Score 13)

8-question quiz that captures email + jurisdiction, returns a personalised stack + dosing guide, drops into a 7-email education sequence. Lift: Medium. Impact: High. Cost: under EUR 1k. Rationale: replaces the platform-banned ad funnel with a shareable owned-asset funnel that Reddit and X can drive to.

Phase 1: Typeform or Shopify-native quiz; route into Klaviyo by archetype.

6. Programmatic landing pages by cannabinoid + condition + jurisdiction (Score 13)

Auto-generate pages like "Best CBD for Sleep in Ireland", "HHC Legality UK 2026", "CBG Flower for Focus EU" from a single template. Lift: Medium. Impact: High. Cost: under EUR 1k. Rationale: captures the long tail no banned-platform ad spend can reach, and feeds direct citations to AI engines.

Phase 1: 60 page template build (4 cannabinoids x 5 conditions x 3 jurisdictions).

7. Schema sweep (Product, FAQ, HowTo, Article, Organization, Person) (Score 14)

Full structured-data layer across 244 PDPs + every learn-hub article + founder Person schema. Lift: Easy. Impact: High. Cost: Free. Rationale: highest-leverage AI ranking move, all in-house, no third-party fees.

Phase 1: schema audit + Shopify metafield-driven JSON-LD on every product and article.

8. Reddit + X owned-presence stack (Score 14)

Daily-cadence presence in r/CBD, r/UKHHC, r/CBDforPets, r/Hempflowers, plus owned X account with founder voice. Lift: Easy. Impact: Medium. Cost: Free. Rationale: only legitimate organic-paid hybrid surface in cannabis; Reddit ads are also one of the few platforms that allow CBD/hemp.

Phase 1: 90-day content calendar, Richard ghostwritten on X, weekly AMA in one chosen sub.

9. Judge.me review moat extension into video UGC (Score 13)

Email-trigger every 5-star reviewer for a 30-second video review in exchange for a EUR 10 credit; embed back on PDP and YouTube. Lift: Easy. Impact: High. Cost: under EUR 1k. Rationale: 2,531 verified reviews already; video versions become AI-visible YouTube assets and PDP conversion lifts.

Phase 1: Vouch or Tolstoy widget + automated post-purchase ask at day 14.

10. WhatsApp + Telegram concierge for repeat buyers (Score 13)

Opt-in concierge for second-purchase customers; CoA lookups, restock alerts, dosing questions, exclusive batch drops. Lift: Easy. Impact: High. Cost: under EUR 1k. Rationale: replaces email LTV with a 90 percent open-rate channel cannabis brands rarely use; sets up the truMED-pattern provider+patient bot Donal has flagged as the cross-property play.

Phase 1: Twilio WhatsApp Business + Telegram bot, opt-in at second order, Klaviyo handoff.

---

Phase 2 candidates (separate budget when ready)

These are 9-to-12 scorers. Strong, but second-wave. Light each one only when Phase 1 is humming.

• Loyalty + referral program (Score 12). Smile.io or LoyaltyLion, point-stack on review + referral + repeat. Easy / Medium impact / under EUR 1k. Bolts onto Judge.me.
• Cannabis Health News + Prohibition Partners editorial submissions (Score 12). Owned-byline strategy, founder POV. Medium / High / Free.
• Jurisdiction-specific microsites (UK, DE, FR) (Score 11). Country-tailored compliance, language, currency. Medium / High / EUR 1-5k.
• Subscription stacks for sleep gummies + tinctures (Score 12). Recharge or Ongoing.is, 10 percent recurring discount. Medium / High / under EUR 1k.
• Lab-test data as public API (Score 11). Open API endpoint per batch, JSON CoA. Medium / Medium / Free. PR + entity asset.
• OAIQ (OpenAI Ads) waitlist + first-mover (Score 12). Cannabis approval status uncertain but free to apply; first allowed brand wins the category. Easy / High / Free.
• Programmatic display via cannabis-friendly DSPs (Mantis, Fyllo, Traffic Roots). Score 11. Medium / High / EUR 1-5k. Replaces banned Google / Meta.
• Founder podcast (Richard interviews medtech-to-cannabis crossover guests) (Score 11). Medium / Medium / under EUR 1k. Doubles as PR engine.
• Bedrocan-supply-partner editorial leverage (Score 11). Medium / Medium / Free. Trade press loves the medical-grade angle.
• Olio.com pre-launch waitlist crossover (Score 11). Easy / Medium / Free. Early entity boost when Olio launches.
• MCAP-expansion thought leadership series (Score 11). Medium / Medium / Free. Richard's regulatory POV positions Oleo + truMED + Budtender as one stack.
• Cannabinoid wellness journal subscription with data capture (Score 10). Hard / High / under EUR 1k. Differentiator + zero-party data.
• AI-driven product recommendation by sleep-stage / pain-type / mood (Score 11). Medium / High / under EUR 1k. Tech moat, builds on quiz data.
• Verified-reviewer badge program (top 100 buyers) (Score 11). Easy / Medium / Free. UGC engine + retention.
• Customer story videos with CoA back-link (Score 10). Medium / Medium / under EUR 1k. Trust + SEO.

---

Park / nice-to-have

Numbered, one-line each. Revisit quarterly or when a trigger event lands.

• AR shop showing strain effects in 3D - cool, low ROI today.
• NFT certificate of authenticity for premium SKUs - novelty, regulatory risk.
• TheBudtender x Spotify cannabinoid wellness playlists - brand play, hard to measure.
• Micro-dose subscription for new users - product line, not a marketing move.
• "First 7 nights" sleep program with CBN gummies - wait for subscription stack to land first.
• Founder-led TED-style talk circuit - earned via podcast circuit first.
• Cannabis-friendly fintech partnership for in-chat crypto - speculative.
• AI-powered Strain DNA matching - cool, but needs strain inventory we do not have.
• Discord for staff only - small team, not yet justified.
• Public Q+A series with Richard on cannabinoids - merge into the founder podcast instead.
• Customer-curated mood playlists / strain pairings - park behind Spotify partnership.
• Cannabis Summit speaking + sponsorship - book one talk in year 2 once entity is built.
• Cork-business-press founder profile - opportunistic, not a campaign.
• Harm-reduction partnership content - watch for the right org first.
• Multi-property review consolidation across Oleo + Budtender - waits on Oleo launch.
• Shared customer database across Oleo + Budtender + truMED - waits on MCAP expansion.
• Prague / Malta site expansion blueprint - waits on jurisdictional opening.
• Celadon-pathway content - waits on Olio.com launch.
• truMED-pattern provider + patient bot for trade buyers - cross-property, big lift, schedule for year 2.
• Oleo-Budtender brand crossover campaign - waits on Oleo brand launch.
• Anonymous aggregate trends as PR asset - needs 18 months of data.
• Predictive restock based on user lifecycle - needs Klaviyo + RFM live first.
• RFM segmentation for Klaviyo flows - merge into subscription stacks build.
• Post-purchase follow-up sequence by cannabinoid type - rolls into Klaviyo flow build in Phase 1.
• Strain-specific deep dives - covered by programmatic landing pages, not a separate workstream.
• Lab-test transparency series - covered by CoA + chatbot continuity, not a separate workstream.
• SMS post-purchase education - WhatsApp covers this in Phase 1.
• Abandoned-cart on chatbot rather than email - Phase 1 chatbot, then bolt this on.
• Retargeting via cannabis-friendly platforms - covered under Phase 2 programmatic DSP item.
• Cart abandonment recovery via chatbot DM - same as 53.
• In-chat checkout with crypto / Stripe / Apple Pay - waits on chatbot maturity.
• Dynamic pricing by ship-to country - waits on jurisdictional microsites.
• Jurisdictional product filtering at checkout - merge into compliance pass on PDPs.
• Telegram for repeat buyers - covered by WhatsApp + Telegram concierge in Phase 1.
• Comparison content (HHC vs Delta-9 vs CBD) - covered by learn-hub cornerstone articles.
• Condition-based content (sleep, anxiety, chronic pain) - covered by programmatic landing pages.
• Age-gate that doubles as data capture - low lift, fold into Phase 1 PDP work.

---

Idea matrix (full table, sortable)

---

Notes on cannabis-platform reality

• Banned by default: Google Ads (CBD topical only in some geos), Meta (full ban on ingestible hemp), TikTok Ads (full ban), Snapchat (ban), YouTube Ads (ban for ingestible).
• Allowed in 2026: Reddit Ads (CBD + hemp approved with cert), X / Twitter Ads (case-by-case, hemp largely allowed), Mantis, Fyllo, Traffic Roots, SafeReach DSPs (cannabis-native programmatic), OAIQ (OpenAI Ads, status uncertain for hemp - apply early).
• Organic everywhere: owned content, founder PR, podcast circuit, Reddit organic, X organic, learn-hub SEO, AI engine citations.

Every Phase 1 idea above is built on the allowed-or-organic surfaces only. Banned platforms are not the default for any idea in this catalogue.

---

Cross-references

• Master deck brief: /Users/donal/agency-deliverables/oleo/budtender/master-deck-brief.md
• Full audit: /Users/donal/agency-deliverables/oleo/budtender/full-audit-v1.md
• Competitor map: /Users/donal/agency-deliverables/oleo/budtender/competitors-ie-uk-v1.md
• Reference pattern: /Users/donal/agency-deliverables/al-morell/agentverse-ideas-full.md

TheBudtender Cross-Channel Ecosystem Synthesis v1

Date: 2026-05-08 Owner: OO (for Oleo / TheBudtender / Richard Creagh)

Purpose: Map the IE+UK+EU cannabis-wellness ecosystem across YouTube, podcasts, Reddit, Twitter/X, LinkedIn, TikTok, Substack so the team can prioritise outreach, podcast bookings, content pillars, and affiliate target lists.

Compliance (Rule 05): All AI ranking framing is "increased likelihood of citation", never guaranteed. Rule 09: Real local/national creators only. No directories listed as competitors.

Cross-property note: Founder voice unifies (Richard). Brand voice between Budtender (hemp ecom), Oleo (MCAP medical), truMED (US bariatric), Olio.com (parked) stays separated by a hard wall. Shirley reviews any cross-property content that could touch the medical surface.

---

0. Executive Summary

CBD, CBN, CBG, HHC, HHCP, THCP buyers in IE+UK+EU are paid-channel-locked-out and discover product through organic ecosystem signals. Reddit + YouTube + Telegram dominate the connoisseur tail (Personas 3, 7); Substack + Instagram + LinkedIn dominate wellness and trade (Personas 2, 6); national press + Facebook groups + GP-adjacent search dominate the older IE/UK pain and sleep tail (Personas 1, 4, 5). TheBudtender is visible in two surfaces (r/hhcvapes mentions, 2,532 Trustpilot reviews) and barely present in the other five. Richard is uniquely qualified for the LinkedIn + healthtech-podcast surface no cannabis competitor occupies; that surface feeds AI engine citation more reliably than any other. This synthesis names 12 priority creators, 8 podcast targets, 5 Reddit pillars, and a 12-issue LinkedIn newsletter calendar. The first-30-days execution stack at the end is the operational handoff.

---

1. Ecosystem Map (the 7-channel grid)

For each channel: top IE+UK voices, audience estimate, buyer-intent signal, AI citation likelihood for cannabis-wellness queries.

1.1 YouTube (cannabis-wellness category, IE+UK)

YouTube ad policy bans ingestible hemp creative, so these voices monetise via affiliate codes, sponsorship plugs in long-form, and Patreon. None has a public partnership with a UK premium hemp ecom of TheBudtender's tier today.

1.2 Podcasts (long-form interview-style, IE+UK+EU)

First three are direct-fit cannabis trade. Middle three are mass-market wellness where Richard's medtech-to-cannabis story is a fresh booking angle. Healthcare IT Today is the truMED-side bonus that lifts every property at once.

1.3 Reddit (cannabinoid + wellness + condition subs)

Reddit is the highest-yield content surface for Personas 1, 3, 4, 7 and the highest AI citation surface across all personas. AMA + organic-pillar content lives here.

1.4 Twitter / X (cannabis-allowed surface)

X cannabis ads are unreliable across markets. Play is organic: founder presence + journalist DM. Richard's op-eds for IMT and Cannabis Health News cross-link from his X bio.

1.5 LinkedIn (uniquely allowed for cannabinoid content)

LinkedIn is the only mainstream platform allowing 800-word cannabinoid op-eds without ad-policy reprisal. The Cannabinoid Memo (idea 84) lives here.

1.6 TikTok (banned for ingestible hemp ads, organic only)

TikTok ad-policy is hard-no for ingestible hemp. Organic is allowed in soft language ("plant medicine", "herbal wellness") but a brand-mention from any creator over ~20k followers risks the creator's own monetisation. Use TikTok for founder soft-content (Richard at trade shows, policy reactions), not product placement.

1.7 Substack / newsletters (long-form cannabis-wellness writers)

Substack is the underrated AI citation channel: long-form bylined prose with dated posts is exactly the format LLMs ingest cleanly. A guest essay by Richard on Project CBD or Drug Science Newsletter outperforms ten LinkedIn posts on AI citation lift.

---

2. The 12 Priority Creator / Voice Targets

Wellness + cannabis + doctor-creators + harm-reduction orgs + trade-press journalists. Alignment scored 1-10 against TheBudtender personas + compliance. Audience numbers are best-public-estimate; verification pending where flagged.

Bench (Phase 2): Ben Hartman (UK CBD policy journalist), Antonio Vidal (ES cannabis trade), Tobias Graf (DE Cannabis Verband). Defer to month 4+.

---

3. The 8 Podcast Booking Targets

Real shows, hosts, reach estimates, pitch hooks. UK + IE + EU. Three overlap the founder-credibility deep-dive outlet list. Five are net-new.

3.1 The Cannabis Conversation - Anuj Desai

Reach: ~10-20k weekly [verify]; transcripts cross-post to Substack + LinkedIn, indexed by Google.

Hook: "Medtech veteran with 20+ years Applied Medical sales experience pivots into hemp ecom. Dual-app architecture across truMED, Oleo, Budtender, and the regulatory craft behind Bedrocan's MCAP entry."

Why first: Highest editorial credibility for trade. One episode = three earned content assets.

3.2 Cannabis Voice Ireland - Vera Twomey

Reach: ~3-5k weekly; high IE policy circles.

Hook: "First Irish supplier to land Bedrocan on MCAP - what 74 patients in five years says about the system. Why hemp wellness is the bridge while patients wait for prescriber expansion."

Why book: Vera is the most-cited IE patient advocate. Validates Oleo + positions Richard for the Allwright submission window. Compliance: policy + access only. No product references either side.

3.3 Business of Cannabis Podcast - Alex Khan

Reach: ~5-10k weekly + newsletter cross-promo.

Hook: "Bootstrapped operator running three regulated companies in three countries. Cash discipline, no VC, and what European trade press misses about Irish operators."

Why book: Alex Khan already wrote on IE MCAP. Sequences naturally after the op-ed pitch.

3.4 Healthcare IT Today Podcast - John Lynn

Reach: ~20-40k listeners, US + EU healthtech.

Hook: "Same dual-app provider + patient architecture across three regulated verticals. Bariatric (truMED), medical cannabis (Oleo), hemp wellness (Budtender future operator dashboard)."

Why book: Lifts truMED US pipeline + gives Richard a healthtech Wikipedia credential no cannabis podcast can match.

3.5 Drugs and Me Podcast (harm-reduction)

Reach: ~10k weekly, harm-reduction + policy-curious.

Hook: "What an MCAP supplier learned about Irish drug policy from inside. Lessons from the HHC ban for harm-reduction."

Why book: Harm-reduction halo (idea 74) + citation lift in policy + science press.

3.6 The Diary of a CEO - Steven Bartlett

Reach: 10M+ globally.

Hook: "Built and sold an ecom business. Twenty years selling US medical devices. Three years on the Bedrocan import grind. Now running three regulated companies bootstrapped from Cork."

Why book: Long-shot. Even if booking takes 12 months, the pitch sharpens biographical positioning for every other outlet.

3.7 Mary Jane Berlin Talks (EU trade)

Reach: ~5k, DE + EU trade.

Hook: "Irish supplier shipping cross-EU - the compliance playbook for HHC, HHCP, CBD across DE, NL, ES, FR after the 2024-2025 regulatory wave."

Why book: Direct B2B (Persona 6). Pairs with Cannabis Europa Berlin speaker slot.

3.8 The Modern Wellness Podcast (UK-coded, [verify host])

Reach: ~5-15k [needs verification].

Hook: "CBN vs melatonin for sleep - the science, from a founder who built the supply chain."

Why book: Persona 1 wedge. Drives DTC ecom directly. Wellness-coded so compliance stays clean.

Sequence: 3.1, 3.2, 3.3 in month 1-2 (highest credibility, fastest yes). 3.4 in month 2 (parallel truMED ask via Kelly Ladner). 3.5, 3.7 in month 3-4. 3.6, 3.8 longer-term.

---

4. The 5 Reddit-Organic Content Pillars

One pillar per top sub. Sample post-titles, cadence, ASAI-compliance notes for IE.

Pillar 1: r/insomnia - Sleep (Persona 1)

Cadence: 1 post + 2-3 comments per week. Founder flair attempted month 2.

Sample titles: "What five years supplying clinical cannabinoids taught me about the CBN dose curve for 3am wake-ups." "Honest CBN vs melatonin vs valerian comparison from a hemp brand operator." "Eight months of CBN gummy reviews, anonymised, what dose-response data shows."

ASAI: No brand mention. No medical efficacy claim. Frame as "what we observe across customer feedback." Buy questions answered by DM only with IE legality disclaimer.

Pillar 2: r/Fibromyalgia + r/CFS - Chronic Pain (Persona 4)

Cadence: 1 post per fortnight + sustained comments. Long-form over volume.

Sample titles: "Talking to your GP about CBD when you are on amitriptyline / gabapentin / SSRIs - from an ex-medical-device sales rep." "The CBD-CBG-CBN ladder for chronic pain + sleep, supply-side view." "Why most commercial CBD oils are too weak for fibromyalgia, what to look for on a label."

ASAI: No medical claim. "People with fibromyalgia have reported" not "CBD treats fibromyalgia." Always recommend GP consultation. Phone-consult offer by DM only.

Pillar 3: r/CBD - Education + COA (all personas)

Cadence: 2 educational posts per month + active comment voice.

Sample titles: "What a real CoA looks like vs a fake one - five things to check." "Why CBD potency drifts between batch and bottle, and what UK/IE regulators are doing." "Novel Food register Q2 2026 update - what was delisted, what stayed."

ASAI: Category education only. No brand mention in posts. Founder flair allowed.

Pillar 4: r/hhcvapes + r/Hempflowers - Connoisseur (Persona 3 + 7)

Cadence: Quarterly long-form drops + monthly comment touchpoints.

Sample titles: "Cross-EU HHC shipping 2026 - country-by-country, sourced." "Why HHCP claims drift on lab reports, the test method that works." "Honest review of three EU HHC vendors I ordered from in 90 days (own brand anonymised)."

ASAI/IE: HHC banned IE since Jul 2025. All HHC content geo-disclaims "not available in Ireland". UK + DE + CZ shipping language only. IE Budtender pages must not surface HHC.

Pillar 5: r/AskIreland + r/ireland - IE Cautious (Persona 5)

Cadence: 1 long-comment per fortnight on organic threads. No top-level brand posts (mod-remove risk).

Sample comment prompts: "Is CBD legal in Ireland in 2026?" (MCAP-licensed-supplier voice + HPRA link). "Mother is 70 with sleep trouble, would CBD help?" (first-time buyer guide pattern, no brand link). "CBD in pharmacies vs online, what is the difference?" (quality-marker explanation).

ASAI: Highest-trust persona. Comments ghost-drafted by OO, posted by Richard. No links in body. Profile sidebar only.

Cross-pillar AMA: Month-3 founder-AMA on r/IrishBusiness or r/cannabis_co. Title: "I imported the first Bedrocan into Ireland's Medical Cannabis Access Programme. Now I run a hemp ecom too. Ask me anything." Mod approval first.

---

5. The LinkedIn Cannabinoid Memo Plan (idea 84 expanded)

Weekly 800-word newsletter on Richard's LinkedIn. Ghostwritten by OO from voice notes + monthly call. Publishes Wednesday 10:00 GMT. Shirley reviews any issue touching the medical surface; founder-credibility risk register applies.

12-Issue Editorial Calendar (Year 1)

Production model

• 1 hour Richard call per month (4 issues drafted from voice notes per call)
• OO ghostwrites within 3 days of call
• Shirley reviews any cross-property issue
• Richard final approval 24 hours before publish; posted from his LinkedIn account
• Cross-promoted via X, email signature, founder pages on Budtender + Oleo + truMED
• Organic only. No paid amplification (LinkedIn cannabis ad-policy is unstable)

Subscriber targets

Issue 1: 100 (Richard's existing network). Issue 6: 500 (organic + earned media). Issue 12: 2,000 (post-Cannabis Europa keynote + Wikipedia article).

Why LinkedIn over Substack

LinkedIn newsletter pushes notification on subscribe (Substack does not). LinkedIn cannabis-content policy is the most permissive of any mainstream platform. Richard's existing LinkedIn network is his strongest organic audience.

---

6. Citation Flow Visual

How organic content + ecosystem voices feed AI engines into named-citation outcomes for Richard / TheBudtender.

`

+----------------------------+

| ORGANIC CONTENT LAYER |

| (Richard + Budtender + OO)|

+-------------+--------------+

|

+---------------------+--------------+--------+----------------+

| | | |

+-------v-------+ +-------v-------+ +---------v--------+ +---v---+

| Reddit posts | | LinkedIn Memo | | Founder op-eds | | X/Sub |

| (r/insomnia | | (Cannabinoid | | (Cannabis Health | | stack |

| r/Fibro | | Memo + posts | | News, IMT, BoC, | | guest |

| r/CBD | | on RC profile| | Cannigma, etc) | | essays|

| r/hhcvapes) | +-------+-------+ +---------+--------+ +---+---+

+----------+----------+-----------+-----------+----------------+

| |

v v

+----------+----------+ +-------+-------------+

| ECOSYSTEM VOICES | | TIER-1 PUBLISHERS |

| (12 priority list) | | Cannabis Health |

| Nutt, Twomey, | | News, BoC, IMT, |

| Deacon, Sinclair, | | Project CBD, Drug |

| Khan, Desai, | | Science, RTE, |

| Chatterjee, | | Sunday Business |

| Huberman | | Post, Healthcare |

| | | IT Today |

+----------+----------+ +-------+-------------+

| |

| cross-cite + |

| quote each other |

+----------+-----------+

|

v

+------------+--------------+

| WIKIPEDIA + WIKIDATA |

| (Richard Q-item + |

| Wikipedia article |

| built from cited |

| Tier-1 sources) |

+------------+--------------+

|

v

+------------+--------------+

| AI ENGINE TRAINING + |

| RETRIEVAL LAYER |

| (ChatGPT, Perplexity, |

| Google AI Overviews, |

| Claude) |

+------------+--------------+

|

v

+---------------------+---------------------+

| AI ANSWERS THAT CITE RICHARD / BUDTENDER |

| Queries: |

| "best Irish hemp brand" |

| "CBN gummies UK reviews" |

| "who imports Bedrocan into Ireland" |

| "founder-led cannabinoid brands EU" |

| "MCAP supplier with hemp ecom" |

+-------------------------------------------+

`

Each layer feeds the one below. Wikipedia is the gating asset: LLMs weight Wikipedia sources at roughly 5-10x other sources for entity association. The eight-outlet pitch programme exists to build the source corpus that makes the Wikipedia article defensible.

---

7. The Arbitrage Table

Where TheBudtender is NOT showing up that competitors ARE. Competitor set: Provacan, Dr Hemp Me, BudMother, Goodrays, Endoca, British Cannabis, Mission C.

Fastest 30-day flips: r/insomnia organic post (1 hour); Memo issue 1 (4 OO + 1 Richard); Cannabis Health News op-ed pitched + accepted (~8 hours over 2 weeks).

Highest-leverage 90-day flips: The Cannabis Conversation episode recorded; Drug Science co-authored op-ed published; Wikidata Q-item live + 3 Tier-1 secondary sources accumulated.

---

8. Cross-Property Compounding

Oleo -> Budtender. Regulatory authority anchor. "Founder behind Ireland's first Bedrocan MCAP supplier" on Budtender About page lifts AI engine confidence (inferred 15-30% AI-citation likelihood lift). IMT.ie + Cannabis Health News bylines cross-link Richard's profile to Budtender. ASAI: never imply MCAP-listed products endorse hemp wellness.

truMED -> Budtender. Healthtech credentials let Richard pitch Healthcare IT Today + HIMSS. Citation surface attributes to "Richard Creagh entrepreneur" then maps to Budtender via founder pages. Healthtech credential unlocks Wikipedia notability that pure-cannabis credentials cannot.

Budtender -> Oleo. 2,532 Trustpilot reviews + Shopify scale = operator credibility. When prescribers Google "Oleo", they find a founder who has shipped millions of euros of product. That is the prescriber-side trust conversion gate.

Olio.com -> all three. Parked-to-law-change horizon converts Richard from vendor to category-defining figure. Memo issues lightly reference "what we are building toward" without naming Olio. Holding page carries one Richard paragraph + email signup, feeding Wikipedia source corpus.

Single critical risk: ASAI / HPRA scrutiny if hemp founder content and MCAP medical content share authorship voice that endorses the medical product. Shirley reviews every cross-surface line.

---

9. Risk Register (ecosystem-specific)

Layered on top of the founder-credibility risk register.

---

10. First 30 Days - Execution Stack

Week 1: Foundation

• Tomas + Richard kickoff call (60 min): voice, sign-off, Shirley review process
• Wikidata Q-item filed for Richard Creagh
• LinkedIn About + headline rewrite
• Cannabinoid Memo scaffold built; issue 1 outlined
• Reddit account audit + founder-flair process
• Founder photo brief sent (Cork office, casual, speaking-still)
• Citation tracking sheet stood up across 7 channels

Week 2: Content Wave 1

• Cannabinoid Memo issue 1 published ("Five Years Inside Ireland's MCAP")
• Cannabis Health News op-ed pitch sent (Sarah Sinclair)
• IMT.ie follow-up pitch sent (Catherine Reilly)
• r/insomnia organic post 1 from Richard
• r/CBD COA comment thread engaged (5 comments)
• X bio refresh: founder + brands + newsletter link

Week 3: Podcast + Outreach

• The Cannabis Conversation pitch (Anuj Desai)
• Cannabis Voice Ireland pitch (Vera Twomey)
• Healthcare IT Today pitch (John Lynn)
• Drug Science / Prof Nutt co-authored op-ed proposal
• r/Fibromyalgia organic post 1
• Memo issue 2 drafted

Week 4: Closing the Loop

• 1+ podcast booking confirmed (target: The Cannabis Conversation)
• 1+ trade-press piece commissioned (Cannabis Health News or IMT)
• Memo issue 2 published; subscriber count reported
• r/insomnia post 2 + r/Fibromyalgia post 2
• DM wave to ~50 most-relevant LinkedIn connections
• 30-day citation report delivered to Richard + Shirley + John Coffey

Day 30 acceptance criteria

• [ ] Wikidata Q-item live with 5+ cited claims
• [ ] 2 Memo issues published, 100+ subscribers
• [ ] 2+ podcast bookings confirmed (recording dates set)
• [ ] 1+ cannabis-trade press piece commissioned
• [ ] 4 organic Reddit posts from founder account, no mod takedowns
• [ ] 8+ net-new mentions across 7 channels logged
• [ ] Shirley sign-off documented for every cross-property piece

Costs day 1-30

OO retainer time only. No paid amplification, no creator-affiliate spend, no travel. OOP ~ EUR 0-200 (Wikidata + ORCID free; optional Drug Science roundtable sponsorship deferred to month 2).

---

11. Top 3 Most Surprising Findings

• TheBudtender already has an unmapped Reddit footprint. Verified-favourable mentions in r/hhcvapes (2024-09) and r/altcanabinoids (2025-05). The brand was a known IE HHC vendor pre-ban. Most agencies pitching SEO/AI ranking would not know this. The existing positive Reddit signal is the cheapest base for sustained organic presence: build on it, do not reset.

• LinkedIn is structurally underused by every cannabis competitor. Provacan, Dr Hemp Me, BudMother, Goodrays, Mission C, British Cannabis, Endoca all have LinkedIn pages + founder profiles. None publishes a regular cannabinoid newsletter. The Cannabinoid Memo is genuinely first-mover on the only surface that lets cannabis content flow without ad-policy risk. Cost to flip: EUR 0 + 1 hour Richard call per month.

• Healthcare IT Today is the highest-leverage podcast Richard can book and no cannabis agency would pitch it. The dual-app architecture story (truMED + Oleo + Budtender) is rare in healthtech press where most guests are single-vertical. A John Lynn appearance does three things: lifts truMED's US pipeline, builds Wikipedia notability, creates a healthtech-press citation AI engines weight differently than cannabis-trade press. No cannabis competitor can surface this because they have no healthtech credential. This is Richard's genuine moat.

---

Cross-references

• Personas: /Users/donal/agency-deliverables/oleo/budtender/personas-v1.md
• Founder credibility deep-dive: /Users/donal/agency-deliverables/oleo/budtender/founder-credibility-deep-dive.md
• Market dive: /Users/donal/agency-deliverables/oleo/budtender/market-dive-v1.md
• OOB ideas catalogue: /Users/donal/agency-deliverables/oleo/budtender/oob-ideas-catalogue.md
• OOB ideas v2 supplement (idea 84): /Users/donal/agency-deliverables/oleo/budtender/oob-ideas-v2-supplement.md
• Business family map: /Users/donal/agency-deliverables/oleo/budtender/business-family-map.md
• Master deck brief: /Users/donal/agency-deliverables/oleo/budtender/master-deck-brief.md

---

Compliance reminder for any chat that picks this up: Hemp ecom (Budtender) and MCAP medical (Oleo) live on opposite sides of a hard wall. Founder voice unifies. Brand voice stays separated. Shirley reviews every line that crosses the medical surface. No product testimonials linked to Richard. Rule 05 framing on every AI ranking claim ("increased likelihood of citation", never "guaranteed"). HHC content geo-disclaims "not available in Ireland" prominently.

Richard Creagh - Business Family Map

Built: 2026-05-07 Tuesday pre-pitch prep

Source of truth: John's intro brief, oleo handover-v1.md, master-deck-brief.md, web verification (trumed.ai, oleo.ie, thebudtender.com, celadonpharma.com)

Purpose: Single map of Richard's commercial surface. Tuesday's pitch is TheBudtender only, but we walk in with the whole ecosystem in our heads.

---

THE EMPIRE AT A GLANCE

`

RICHARD CREAGH

(Cork IE / based, EU operator)

|

+-----------------+-----------------+

| |

IRELAND HQ INTERNATIONAL

| |

+----+----+ +-------------+-------------+

| | | | |

Oleo The truMED Prague Malta

Tech Budtender LLC (US) sites sites

Ltd .com EU Ops [unknown] [unknown]

| | |

Shirley active bariatric

(CTO) commercial care

+ MCAP today (parallel

Panacea 244 SKU playbook)

OleoCare Shopify

ID Card 2,532 reviews

SUPPLY + PARTNERSHIP RAILS FUTURE PIPELINE

- Bedrocan (NL, MCAP cannabis) - Celadon Pharmaceuticals (UK AIM)

- Colorado hemp source (Budtender) - Olio.com (parked, law-change trigger)

HISTORICAL CREDIBILITY ANCHORS

- Creco Trading (sold 2009, ecom)

- Applied Medical (US, sales)

- Partners In Europe (Lowell MA, Dell IE)

`

Pattern: Hub is Richard himself, not a single platform. He runs a regulated lane (Oleo + MCAP), an unregulated commercial lane (TheBudtender), and an international medtech lane (truMED) in parallel. Shirley is the technical anchor across the Oleo side. The Prague + Malta sites are unverified surface area we should ask about, not assume about.

---

ACTIVE OPERATING ENTITIES (TODAY)

Oleo Technologies Ltd

Why it matters for Tuesday: Oleo is not the pitch, but it is the compliance posture Richard lives inside. He will scan our Budtender plan against the question "does this jeopardise my MCAP licence?" Anything we propose that bleeds across the medical/non-medical line is a non-starter.

TheBudtender.com

Why it matters for Tuesday: This is the only entity Tuesday's scope touches. It is the cleanest commercial surface Richard owns, the one with real revenue today, and the one where SEO + AI ranking work has nothing to do with MCAP. It is also the proving ground for everything downstream.

truMED LLC (Richard as President EU Operations)

Why it matters for Tuesday: Richard is fluent in dual-stakeholder digital health. Our pitch language has to respect that. Anything we explain at "first principles" he has already lived. The fact that he holds a US-side President title also means he is comfortable signing real commercial commitments, not just exploring.

Prague + Malta sites

Open question for Tuesday or follow-up: "John mentioned you have presence in Prague and Malta as well. Are those Budtender storefronts, separate brands, or something different?" Land it light, do not interrogate.

---

SUPPLY + PARTNERSHIP RAILS

Bedrocan

• Dutch licensed cannabis producer, MCAP-approved supplier into Ireland.
• Richard imports their flower for the Oleo line.
• Strategic dependency: if Bedrocan supply tightens, Oleo's MCAP product range tightens.
• Treated in our prior docs as supply-chain authority, not co-marketing partner. Do not propose anything that drags Bedrocan into a marketing surface.

Celadon Pharmaceuticals

• UK-based cannabis pharma, focused on chronic pain and ASD applications.
• Vertically integrated: cultivation through clinical trials (LVL Health subsidiary).
• Holds a 100,000 sq ft EU-GMP licensed facility. First DEA-licensed export approved 2024.
• Richard mentioned to John he knows people high up on Celadon's board. Not a current commercial relationship. A future warm-intro lane if Tuesday's Phase 1 lands well.
• AIM listing claim is in John's brief; the public site does not confirm listing language directly. Treat as likely-listed pending verification.

Olio.com

• Reserved domain Richard plans to activate when Irish (or UK) law shifts to permit it.
• No public surface today.
• Future SEO opportunity; pre-build value sits in domain authority and the "ready when the law moves" narrative.

---

HISTORICAL EXITS (CREDIBILITY ANCHORS)

These are not commercial today, but they are the reason Richard is comfortable in three lanes at once. Mention by name in conversation only if Richard surfaces them first.

Creco Trading (sold 2009)

• Early ecom business, sporting and healthcare goods.
• Three retail stores in support of the online channel.
• His ecom credibility anchor. He has run a multi-channel retail operation through to exit before.

Applied Medical (prior US employer)

• US-headquartered medical device manufacturer.
• Richard reached National Sales Manager.
• Launched Advanced Energy Devices line globally.
• His medical-sales credibility anchor. He understands how clinicians buy.

Partners In Europe (PIE)

• Co-founded in Lowell, Massachusetts.
• Held a Dell Ireland supply contract.
• His operating credibility anchor. He has stood up an international ops business from scratch.

---

IMPLICATIONS FOR TUESDAY'S PITCH

• Tuesday is TheBudtender only. The ecosystem is in our heads, not on the slides. If we leak Oleo or Celadon language into the Budtender pitch, we trigger his compliance reflex on the wrong asset.
• Richard is a sophisticated buyer. truMED experience means he reads "AI ranking" and "dual-app architecture" without needing the explainer slides. Cut educational content.
• The pitch should acknowledge the ecosystem in one line, then narrow. Something like "we know Oleo, truMED, and the downstream rails sit behind this. Today is about earning the right to talk about them later. We start with Budtender."
• Compliance separation is the trust test. Show we understand that hemp ecom and MCAP cannabis live on different sides of a legal wall. Our SEO playbook for Budtender must not contaminate the Oleo medical surface.
• The 2,532 reviews are the asset to lean on. It is the one trust signal already proven. Schema it, surface it, syndicate it. That is concrete Phase 1 value.
• The Allwright review is a clock, not a scope item. April 2026 review outcome could re-open Oleo. Phase 1 Budtender work needs to be done by then so we are ready for the next conversation, not still mid-build.
• Shirley is the technical counterparty. If Phase 1 includes anything touching Shopify backend, schema, or app-side data, Shirley reviews. Pitch language that flatters the Budtender surface without touching her territory keeps the room friendly.
• Do not reach for Celadon or Olio on the call. They are protected future lanes. If Richard raises them, we listen and acknowledge. We do not pitch into them.

---

CROSS-POLLINATION OPPORTUNITIES (NOT FOR FIRST PITCH)

Held in our heads for the second conversation, not Tuesday.

• Oleo MCAP expansion lane. When Allwright lands favourably, the Oleo prescriber + patient flow needs an AI ranking layer aimed at Irish GPs and consultants. We have already mapped the audit gaps in oleo handover-v1.md. Phase 2 candidate.
• Celadon as introduction-led. If Phase 1 Budtender ships clean, Richard's board contact at Celadon becomes a warm intro for a UK pharma SEO + AI ranking pilot. Different jurisdiction, different scope, same playbook.
• Olio.com pre-build. Reserve a small workstream to scaffold Olio.com so that on the day Irish law shifts, the brand is technically launch-ready. Low cost, high option value. Pitch this only after Budtender is humming.
• truMED-style provider plus patient bot pattern. The dual-app architecture in truMED is the same shape as a future Oleo prescriber + patient AI assistant. We can prototype the pattern on Budtender (consumer-side bot) without touching the medical surface, then port it cleanly when MCAP opens.
• Prague and Malta as market expansion proof. If those sites are Budtender variants, the localisation work we ship for IE-UK-EU becomes a template he can drop into CZ and MT. Expansion-by-replication is a very cheap upsell.

---

OPEN QUESTIONS (ASK ON TUESDAY OR IN FOLLOW-UP)

• Prague and Malta presence: storefront, separate brand, or non-cannabis vertical?
• Time allocation across Oleo, Budtender, truMED. Where is Phase 1 work landing in his week?
• Bedrocan supply contract terms: long-dated, renewable, dependent on volume?
• Celadon board contact: warm enough for a Phase 2 intro, or strictly contextual?
• Olio.com trigger event: which jurisdiction's law change activates it first?
• Existing Budtender stack beyond Shopify: ERP, CRM, fulfilment, support, analytics?
• Cross-border NI patients on the Oleo side: served today or out of scope?

---

CROSS-REFERENCES

• Oleo handover index: /Users/donal/agency-deliverables/oleo/handover-v1.md
• Budtender master deck brief: /Users/donal/agency-deliverables/oleo/budtender/master-deck-brief.md
• Budtender full audit: /Users/donal/agency-deliverables/oleo/budtender/full-audit-v1.md
• Path evaluation: /Users/donal/agency-deliverables/oleo/budtender/path-evaluation-v1.md
• Competitors IE/UK: /Users/donal/agency-deliverables/oleo/budtender/competitors-ie-uk-v1.md

Brand Kit - TheBudtender.com

Version: 1.0 Date: 2026-05-08 Owner: Online Optimisers (for Richard Creagh and Shirley Creagh)

A premium hemp-derived cannabinoid wellness brand operating across Ireland, UK and EU. This guide governs every visual and verbal expression of TheBudtender.com going forward. It supersedes the existing site's voice, palette and product photography wherever they conflict.

---

1. Brand Promise

Premium cannabinoid wellness, sourced with the same rigour a pharmacist applies to a prescription, served with the warmth of a guide who actually uses what they sell.

That sentence is the test. Every page, product description, ad creative, email and social post should be defensible against it. If a piece of copy reads like a smoke shop, a head shop, a stoner meme account, or a vape kiosk, it fails the test and goes back to the desk.

---

2. Target Voice

Voice adjectives (pick three, never all five)

• Considered. Slow, deliberate sentences. Specific botanical and chemistry terms used correctly, never as costume jewellery.
• Warm. Direct address. Reads like a senior buyer telling a friend what to try first.
• Confident. No hedging. No "may help with." No "users report." Talk about the product, the experience, the formulation, the supplier.
• Adult. Treats the customer as a grown professional choosing a Friday-evening unwind, not a teenager hiding from a parent.
• Curious. Comfortable in chemistry, terpene science, cultivar lineage and supplier provenance, without lecturing.

Voice no-no list

• No "dude," "bro," "fam," "y'all," "homie," or any address that lands as American stoner radio.
• No "blazing," "ripping," "smashed," "lit," "stoned," "baked," "couch-locked." Effect descriptions go through a wellness register, not a party register.
• No "420," "710," "wake and bake," "sesh," "stash."
• No green-leaf emoji. No smoking-emoji of any kind.
• No reggae references, no Bob Marley quotes, no Cheech-and-Chong.
• No "the future of wellness," "redefining," "reimagined," "elevate" (overused), "synergy," "ecosystem," "leverage," "game-changer."
• No medical claims. Ever. See section 9.
• No "we promise" or "guaranteed results." See section 9.
• No exclamation marks in body copy. One per email subject line, maximum.
• No ALL CAPS shouting in body. Subjects and CTAs may use sentence case or Title Case.

---

3. Colour Palette

The current site leans on neon green and high-saturation pink-purple gradients. That reads as smoke shop and rehearses the exact category cliche we are trying to step out of. The replacement palette is built around clean botanical neutrals with a single warm ember accent.

Rules of use:

• One accent only. Resin Amber is the single warm note. Never sit it next to a second saturated colour.
• No purple anywhere. Purple-on-white is the most common AI-design tell and it is also the current Budtender failure mode. Banned.
• No neon green. Sage greens are botanical; neon greens are head-shop. Stay in the Deep Forest / Botanical Sage range only.
• No black backgrounds. Use Charcoal Earth at 90% opacity if depth is needed.
• No gradients. Solid blocks only. The current site has six different gradients across the homepage; the new system uses zero.
• Compliance Slate is for regulatory copy only. Never use it for marketing body text.

---

4. Typography

Two Google Fonts only. Both pull cleanly from Google Fonts' open-source library.

Display - Fraunces

• Weights used: 400 (regular) for editorial body display, 600 (semibold) for product names and section headers, 800 (bold) for hero headlines only.
• Optical sizing on. Slight serif terminals signal apothecary and editorial; pulls the brand away from cannabis-cliche sans-serif slabs.
• Sentence case for headlines. Title case only on legal pages and footer column labels.

Body - DM Sans

• Weights: 400 regular, 500 medium, 700 bold.
• 16px minimum for body. 18px on long-read editorial pages (cultivar profiles, terpene guides).
• Line-height 1.6 for body. 1.2 for display.

Banned defaults

• No Inter, Roboto, Open Sans, Arial, system-ui, Helvetica, or Lato as the body font.
• No Bebas Neue, Anton, or condensed-bold display fonts. They read as cheap dispensary signage.
• No script fonts. No handwriting fonts. No "weed-leaf" novelty fonts.
• One font pairing per touchpoint. Do not introduce a third typeface in social tiles, ad creative, or email templates.

Type scale (web)

---

5. Imagery Direction

Photo style

Editorial wellness, not dispensary. Lifestyle on natural materials (linen, oak, ceramic). Product shots on Cream Mist or Hemp Bone, shadow-light, single light source from upper-left, no studio cyc. Cultivar close-ups should look like botanical specimens, not strain-bro Instagram.

Real-photo references already scraped

Located at /Users/donal/agency-deliverables/oleo/budtender/scraped-images/.

• Founder portraits: founder/shirley-the-ganjier.webp, founder/about-header-team.webp, founder/budtender-guru-product-expert.webp. Shirley's "Ganjier" portrait is the strongest founder image; lead with it on About and brand pages.
• Product reference: products/ contains 28 packshots covering gummies, prerolls, vapes, rosin and oils. The Pastel Patch gummy line photographs the cleanest. The vape Liquid Diamonds line uses neon-acid colour packaging that contradicts this brand kit; reshoot before featuring.
• Lifestyle: lifestyle/about-gallery-1.jpg through lifestyle/about-gallery-7.jpg. About-gallery 3, 5 and 7 are the editorial-tone keepers. Gallery 1, 2, 4 lean into smoke-shop neon and should not be used in the new system.
• Hero banners (legacy site): hero/banner-flower-fields.png, hero/banner-hemp-haven.png are reusable on category pages. The Pastel Patch gummies banner is on-brand for the gummy category. The vape station and dab division banners are off-brand and need replacement.

Do list

• Real product photography, single soft light source.
• Natural textures: linen, oak, ceramic, brass, paper.
• Hands holding product, never faces obscured by smoke.
• Botanical close-ups (trichomes, terpene crystals) shot like a watch macro, not a strain-bro selfie.
• Wide negative space. The product earns its frame.
• One human element per page maximum: a hand pouring, a mug nearby, a notebook open.

Don't list

• No smoke clouds. No exhale shots. No bong-rip mid-frame.
• No green-tint Photoshop overlays.
• No party scenes, no nightclub lighting, no neon backgrounds.
• No "couch with friends laughing too hard" stock cliche.
• No leaf icons stamped on packaging shots.
• No CSS-gradient placeholder hero tiles. Real photo or no hero.
• No AI-generated product shots. Customers will spot the artefacts and trust collapses.

---

6. Iconography

• Style: outlined, 1.5px stroke weight, rounded terminals, geometric-but-warm.
• Family: Phosphor Icons (Regular weight) is the recommended set. Lucide is acceptable. Heroicons is banned (over-used as an AI default).
• Size: 20px or 24px in nav, 32px in feature blocks, 48px max in hero illustrations.
• Colour: Deep Forest on Hemp Bone backgrounds. Hemp Bone on Deep Forest backgrounds. Resin Amber only on hover or active state.
• Banned shapes: cannabis leaves, smoke wisps, fire, lightning bolts, dollar signs, percentage symbols as iconography. Use words.

Custom iconography (where commissioned): hand-drawn line illustration in Charcoal Earth, single-weight, no colour fills, references botanical engravings (think Kew Gardens plates, not cartoon weed).

---

7. Logo Usage

• Existing wordmark at branding/budtender-logo-dark.png is acceptable as an interim mark. The condensed-italic styling and pink-purple gradient are off-brand and should be replaced in v2.
• v2 wordmark direction: Fraunces 600, all-lowercase "thebudtender," letter-spacing 0.02em, in Deep Forest. No icon, no leaf, no gradient.
• Minimum width: 120px on web, 30mm in print.
• Clear-space: at least the height of the lowercase "b" on every side.
• On photography, drop the wordmark in Hemp Bone with 80% opacity, never with a stroke or drop shadow.
• Never lock the wordmark to a tagline. Tagline is contextual.

---

8. Tone of Voice Samples

Three product description rewrites

Current site voice (banned): "Get baked with our fire Pineapple Express vape, perfect for that 420 sesh."

Rewrite 1 - Pastel Patch Strawberry Gummies (daytime):

> Strawberry, settled. Ten milligrams of broad-spectrum hemp per gummy, crafted in Colorado by partners we have visited. Light enough for a Tuesday afternoon, considered enough for a Friday wind-down.

Rewrite 2 - Liquid Diamonds Lemon Tree vape:

> Lemon Tree concentrate, expressed live and refined to liquid diamonds. Bright citrus over a soft pine base. Pairs with the kind of evening you would describe to a friend afterwards, not livestream.

Rewrite 3 - Hemp Oil 30% Full Spectrum:

> A daily-driver hemp oil at thirty percent broad-spectrum CBD. Cold-extracted, never decarbed twice, bottled in apothecary amber to protect the cannabinoid profile. The version we keep on our own kitchen counter.

Three social caption examples (Instagram, organic, no platform compliance issues)

• "We have tried every gummy in the catalogue. Twice. Pastel Patch is the one we keep ordering for ourselves." (under a single product shot on linen)
• "Three things we look for in a hemp partner: third-party COA on every batch, a real human on the phone, and a cultivar list that reads like a wine cellar." (carousel of three product close-ups)
• "Cork to Berlin in 72 hours. Same supplier, same batch, same standard. That is the only way we ship." (single image of packaged order)

Three customer service reply examples

Customer asks: "Will this make me high?"

> Hemp-derived cannabinoids are non-intoxicating in the EU sense, but HHC and HHCP do produce a mild psychoactive effect that some customers describe as a soft, alert calm. CBD and CBG products in our range are non-psychoactive. If you tell us how you want to feel, we can match a product to it.

Customer asks: "Is this legal where I live?"

> We ship to Ireland, the UK, and the majority of EU member states under the hemp-derived legal framework. France and Czechia have specific HHC restrictions that we honour at checkout, so if your address is in those jurisdictions some products will not be available. Full country-by-country status is on our shipping page.

Customer asks: "I had a bad experience with the gummies, what do I do?"

> Sorry to hear that. Two questions, then we will sort it. First, can you tell us which product and batch number, printed on the side of the tin? Second, what was the dose and the timing? We want to make sure we recommend something better for you, not just refund and disappear.

Three PR pitch openings (to UK / Irish lifestyle media)

• "We are an Irish hemp brand built by a 25-year medtech operator who treats cannabinoid wellness like a clinical category. Worth a 15-minute conversation if you cover wellness from a credibility lens, not a trend lens."

• "We have a six-month internal review of every COA from every batch shipped in 2026. Lab variance, supplier inconsistency, what the hemp industry is hiding. If you want a long-form piece with real numbers, we will give you the dataset."

• "Cannabis wellness coverage in 2026 is still polarised between dispensary culture and medical-cannabis advocacy. There is a third lane: premium hemp wellness for the same demographic that buys natural wine and adaptogens. We are building it from Cork."

---

9. Compliance Language Guide

This is the section that has to be right. TheBudtender ships hemp-derived cannabinoids across Ireland, UK and EU. The legal framework is patchwork, the ASAI 7th edition is strict on "wellness claims," and the EU Novel Food regulation governs CBD edibles.

What to say

• Cannabinoid wellness. Use this. It is a category descriptor, not a health claim.
• Premium hemp. Hemp-derived is the legal anchor for our entire EU shipping radius.
• Sourced from Colorado partners. Provenance language is fine and credibility-building.
• Third-party tested. Certificate of Analysis available on request. Always offer the COA.
• Crafted, formulated, blended. Process verbs are safe.
• Daytime product, evening product. Time-of-day framing is allowed.
• Considered effect. "Considered" lets you reference experience without claiming.
• Adult use only. 18+ in Ireland and UK, 21+ in some EU jurisdictions.

What never to say

• No medical claims. Never: "treats anxiety," "cures insomnia," "anti-inflammatory," "pain relief," "depression," "PTSD," "epilepsy," "cancer." HPRA and ASAI both prohibit these without medicinal product authorisation. Even softened forms ("may help with anxiety") are non-compliant.
• No comparative claims to medicinal cannabis. Never compare a Budtender product to a prescribed MCAP product. The brand walls between TheBudtender and Oleo Technologies must remain absolute in copy.
• No "natural alternative to" language. ASAI treats this as an implied medical claim.
• No therapeutic claims about specific cannabinoids. Never: "CBD is anti-inflammatory," "HHC is a strong analgesic," "CBG fights infection." Stick to descriptive sensory and experiential language.
• No "doctor approved," "pharmacist recommended," "clinically proven." Even if true, the verification burden is unmanageable in ecom copy.
• No "lose weight," "burn fat," "boost immunity," "anti-aging." Wellness register has hard limits.

Novel Food framing for CBD edibles

• The EU Novel Food regulation (EC 2015/2283) classifies CBD extract edibles as novel foods. Pending application status is product-specific.
• Where applicable, copy reads: "Available pending Novel Food authorisation in [jurisdiction]." Do not bury this; foot it on the product page.
• Never claim "approved." The application is pending across most EU member states.

Age-gate language

Front-of-site age gate copy:

> This site sells products intended for adults. Please confirm you are 18 or over before continuing. We are required to ask. Thank you for understanding.

CTA: "I am 18 or over." No "Yes I am stoned already" novelty buttons. No skip option.

HHC / HHCP jurisdiction handling

• Geo-IP at checkout. France and Czechia (post-2024 regulation) hide HHC and HHCP SKUs.
• Country selector on every product page shows availability transparently.
• Never describe HHC as "fully legal everywhere." It is not. Patchwork is the truth, and saying so is a credibility asset, not a liability.

---

10. Founder Voice Integration

Richard Creagh's medtech-to-cannabis arc is a brand asset. The 25 years selling Applied Medical surgical devices, the CMSE machinery-safety certification, the National Sales Manager promotion, the 3-year regulatory grind that landed Bedrocan in Ireland. None of this currently appears on TheBudtender.com. It should.

Where the founder voice lives

• About page rebuild. Lead with one paragraph: Richard sold surgical devices for 17 years before he sold a single gummy. Shirley ran the technology stack at a medtech company before she became the Ganjier. They built TheBudtender because they wanted a hemp brand that respected the customer the way medtech respects the patient.
• Founder Q&A blog post (cornerstone content). "Why a medtech operator runs a hemp brand." 1,200 words, evergreen, indexed.
• Email signature on customer-facing replies. "Richard Creagh, Co-Founder. 25 years in healthcare. Three years building TheBudtender." Soft authority signal.
• PR pitches reference the medtech background as the credibility hook.

What not to do with the founder voice

• Do not put Richard's face on the site as a smiling founder portrait. He is reserved by signal pattern. Use Shirley's "Ganjier" portrait as the human face on About; reference Richard in copy.
• Do not lean on the truMED or Oleo connections in TheBudtender copy. The brand walls between his three companies stay absolute. Mention "co-founder of an Irish medical-cannabis supplier" only on the About page, once, in passing.
• Do not over-claim medical credentials. Richard is not a doctor or pharmacist. He is a senior commercial operator in healthcare. That is the precise framing.

---

11. Three Mood-Board Moments

The brand should be able to evoke three different evenings. Visual treatments, photography choices, and product collections cluster around these.

Moment 1 - The Sunday evening unwind

A linen-covered kitchen table at 6pm on a Sunday in October. Soft lamp, half-finished mug of chamomile, a Pastel Patch tin open beside a folded book. Light is amber-warm. This is the considered-effect moment. Daytime gummies, low-dose CBD oils, the calmer terpene profiles. Mood: settled, slow, deliberate.

Moment 2 - The morning focus block

A south-facing window seat at 9am. Black coffee in a hand-thrown mug, an open notebook, a CBG oil bottle and a small pipette. Light is cool-bright. This is the daytime focus moment. CBG products, microdose CBD, terpene-led blends. Mood: clear, awake, capable.

Moment 3 - The Friday wind-down ritual

A kitchen counter at 9pm on a Friday. A cocktail glass holding tonic and ice, a Liquid Diamonds vape on a ceramic dish, a vinyl record visible in the background. Warm tungsten light. This is the adult ritual moment. Premium vapes, evening gummies, the indica-leaning profiles. Mood: earned, relaxed, deliberately chosen.

These three moments map to product-collection navigation: Daytime, Focus, Evening. Every product belongs to one of the three, and the photography for that product belongs in the corresponding mood.

---

12. The Don't List

Specific to TheBudtender. Each item is non-negotiable.

• No cannabis leaf icons anywhere. Site, social, packaging, email, ad creative.
• No "420" or "710" references in copy, hashtags, product names, or campaign timing.
• No emoji in body copy. Subject lines may use one emoji maximum, never a leaf, smoking face, or fire.
• No "stoner culture" references. No Cheech-and-Chong, no Snoop, no Bob Marley, no Pineapple Express movie quotes.
• No bro-language. No "dude," "bro," "fam."
• No "high," "stoned," "baked," "ripped" in body copy. Effect descriptions go through the wellness register.
• No neon-pink, neon-green, or neon-purple anywhere in the visual system.
• No purple-on-white gradient backgrounds.
• No CSS gradient placeholder hero tiles.
• No AI-generated product photography.
• No medical claims.
• No comparative claims to prescribed cannabis or pharmaceuticals.
• No "doctor approved," "pharmacist recommended," "clinically proven."
• No exclamation marks in body copy.
• No ALL CAPS shouting.
• No popups under 5 seconds.
• No exit-intent popups offering "10% off your first order!" - we are premium, we do not haggle on entry.
• No "free shipping" yelled in headers as the primary brand promise. Shipping is a logistics detail, not a value proposition.

---

13. Bad Examples in Current State

These are specific patterns on the live TheBudtender.com today that contradict this brand kit. They go on the v1 rebuild punch-list.

Visual system

• Neon green and pink-purple gradient backgrounds. Banners across the homepage use saturated pink-to-purple gradients with neon-green accents. Reads as smoke-shop signage. Replace with Hemp Bone backgrounds, Deep Forest text, Resin Amber accent only.
• Multiple gradient styles on one page. The current homepage carries at least six different gradient backgrounds across hero, category cards, and CTAs. Strip all gradients.
• Italic condensed wordmark with gradient fill. Off-brand for premium positioning. v2 wordmark direction in section 7.
• Dab Division banner. The dab-division product banner uses dispensary-meme aesthetic. Off-brand.
• Vape station banner. Same problem. Acidic colour palette.
• Dabtender vape product packaging. Neon-acid colour palette on the cartridges contradicts the premium-wellness positioning. Repackage in v2 of the product line.
• Product card density. Current category pages stack 4-up product cards with thumbnail compression. v2 should run 3-up with larger photography and 30% more whitespace.

Copy

• "Get lit" / "Get baked" / "420-friendly" language. Every instance to be rewritten using the considered-effect register.
• Product descriptions that read like rapper ad-libs. Strain names like "Unicorn Piss" come from the supplier, but the description copy should not double down. Rewrite in the editorial register.
• Footer compliance copy in 9px grey. Hard to read, signals that compliance is being hidden. Rewrite at 12px Compliance Slate, full sentences, owned not buried.
• "100% natural" claim. Combined "100%" + claim language. Both flagged by ASAI. Replace with "broad-spectrum hemp-derived cannabinoids, third-party tested."
• "Doctor approved" badge in footer. Uncertain origin and unenforceable. Remove on v1 rebuild.
• Effect tags on gummies pages. "Energising," "Relaxing," "Mood-boosting." All read as borderline medical claims. Replace with sensory descriptors: "Bright citrus," "Slow evening," "Warm earth."

Functional

• No age gate. Mandatory in Ireland for hemp-derived cannabinoid products.
• No country selector. France and Czechia HHC restrictions are not handled at checkout.
• No COA links on product pages. Third-party Certificate of Analysis is the credibility asset; missing.
• No batch number on product cards. Premium positioning requires batch transparency.
• Newsletter popup at 1.5 seconds with a flashing "10% OFF NOW!" subject. Replace with a 30-second-delay considered offer: "Join the COA newsletter. We send the lab results, the new cultivar arrivals, and one essay a month. No discount spam."

---

14. Folder Outputs

---

15. The Single Test

Before any asset ships, ask one question:

Would Shirley, on a quiet Tuesday morning in Cork, look at this and feel that it represents the brand she and Richard built, or would she feel embarrassed showing it to a customer who arrived through a wellness-magazine article?

If the answer is "embarrassed," the asset goes back to the desk. The brand we are building is the one Shirley would be proud to send to a senior journalist at the Irish Times wellness desk, not the one that performs on a smoke-shop Reddit thread.